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collaboration, it congregates and becomes a temple.  
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Resumo	
 
O funcionamento de cada célula no organismo depende do suprimento de oxigénio e 
nutrientes pelos vasos sanguíneos. Assim, a formação e manutenção de redes de vasos 
sanguíneos é fundamental para o desenvolvimento embrionário, crescimento, homeostasia 
e regeneração. Praticamente todas as redes de vasos sanguíneos são formadas por 
“sprouting” angiogénese, um processo que tem sido extensivamente estudado nas ultimas 
décadas. Ainda que muitos mecanismos celulares e moleculares tenham sido descobertos, 
ainda não é completamente entendido como é que as células endoteliais se dividem 
fornecendo números adequados para a formação de novos vasos  sanguíneos e se 
arranjam convenientemente para dar forma a redes de vasos funcionais. Neste trabalho, eu 
investiguei a hipótese de que YAP e TAZ, as proteínas efetoras finais da via de sinalização 
Hippo, são necessárias para este processo.  
YAP e TAZ são essenciais para o desenvolvimento de novos vasos sanguíneos. Em 
ratinhos sem YAP/TAZ nas células endoteliais os novos botões vasculares são em menor 
número, de forma arredondada e hemorrágicos, e as redes vasculares são mais pequenas e 
carecem de homogeneidade. Os novos botões vasculares contêm poucas protrusões 
celulares e mostram agregação de células endoteliais, denotando falência das células de se 
distribuírem devidamente.  
Vários mecanismos contribuem para este fenótipo. YAP/TAZ promovem a 
proliferação das células endoteliais causada pela estimulação mecânica ao nível das 
junções celulares por estiramento cíclico. Além disso, YAP/TAZ aumentam a migração e os 
rearranjos das células endoteliais, ao mesmo tempo que reduzem a permeabilidade entre as 
células. Assim, YAP/TAZ mantêm a integridade vascular enquanto permitem os aumentados 
movimentos celulares que acontecem durante a brotação de novos vasos sanguíneos. O 
referido efeito na migração celular e na permeabilidade é pelo menos parcialmente 
explicado pelo papel que YAP/TAZ exerce nas junções celulares. Aí, YAP/TAZ aumenta a 
rotatividade das moléculas de VE-Caderina e promove a formação de lamelipodias 
intermitentes associadas a junções, o tipo mais dinâmico de junções aderentes. Isto é 
conseguido pelo menos em parte através da redução de sinalização BMP pela transcrição 
de inibidores de BMP. 
Juntos, estes resultados sugerem um novo modelo no qual YAP/TAZ coordenam 
estímulos mecânicos e sinalização BMP e mantêm a flexibilidade e integridade das junções 
celulares ao mesmo tempo que promovem a migração e rearranjos celulares nos novos 
botões vasculares 
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Abstract 
 
The functioning of every cell in the organism depends on the reliable supply of 
oxygen and nutrients by blood vessels. Because of this, the formation and maintenance of 
blood vessel networks is critical for embryonic development, tissue growth, homeostasis and 
regeneration. Virtually all the vessel networks in the organism form by sprouting 
angiogenesis, a process that has been extensively studied in the past decades. Although 
many cellular and molecular mechanisms have been discovered, it is still poorly understood 
how endothelial cells arise in adequate numbers and arrange suitably to shape functional 
vascular networks. In this work, I investigated the hypothesis that YAP and TAZ, the final 
downstream effectors of the Hippo signaling pathway, are required for this process. 
YAP and TAZ are critical for the development of new blood vessels. In mice lacking 
endothelial YAP/TAZ nascent vessel sprouts are fewer, blunted and hemorrhagic, and blood 
vessel networks are smaller and lack homogeneity. Nascent vessel sprouts show little 
cellular protrusions and aggregations of endothelial cells are found, denoting failure to 
distribute properly. Several mechanisms account for this phenotype. YAP/TAZ promote 
endothelial cell proliferation downstream of mechanical stimulation at cell-cell junctions by 
cyclic stretch. Moreover, YAP/TAZ increase cell migration and rearrangements of endothelial 
cells, at the same time that it decreases endothelial permeability. Thus YAP/TAZ are able to 
maintain vessel integrity while allowing the dynamic cellular movements take place during 
sprouting of new blood vessels. The referred effect of YAP/TAZ on cell migration and 
permeability at least in part depends on their role at cell-cell junctions. There, YAP/TAZ 
increase the turnover of VE-Cadherin molecules and promote the formation of junction 
associated intermediate lamellipodia, the more dynamic type of adherens junctions. This is 
achieved in part by lowering BMP signaling via the transcription of BMP inhibitors. 
Together, these results suggest a new model in which YAP/TAZ coordinate 
mechanical signals and BMP signaling and maintain junctional compliance and integrity 
whilst balancing endothelial cell rearrangements in angiogenic vessels. 
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Chapter	1	-	Introduction	
 
My thesis is about sprouting angiogenesis, the process through which the 
majority of blood vessels in the organism develop. At the start of my PhD the 
homologous proteins YAP and TAZ, the main effectors of the Hippo pathway, had 
drawn significant attention as key regulators of cell behaviour and organ 
morphogenesis in many tissues and organs, however their role during the formation 
of blood vessels had not been investigated. My work thus started with the hypothesis 
that YAP and TAZ are necessary for the formation of blood vessels, and aimed to 
understand their role in endothelial cells during sprouting angiogenesis. 
In this chapter I will introduce necessary information for the understanding of 
my work. I will start with an overview of the cardiovascular system and blood vessels, 
their macroscopic and histologic structure and how they develop through sprouting 
angiogenesis. Next, I will describe YAP and TAZ: their position within the Hippo 
pathway, regulation, roles on cell biology and morphogenesis in general and what 
was known on the role of YAP and TAZ in vascular biology. Finally, I will finish this 
chapter by presenting my research questions and aims.  
 
 
1. PART1.	The	cardiovascular	system	and	sprouting	angiogenesis	
 
1. The	cardiovascular	system	
 
A fundamental characteristic of life, from the most simple to the most 
complex, is that of converting nutrients and gases from the environment into energy, 
and on doing so, sustaining growth, survival and reproduction. In order to achieve 
this all organisms rely on the process of diffusion, which although energetically 
inexpensive is also very slow and only works over small distances. While very simple 
organisms achieve such exchange directly through the cell membrane, the increase 
in body size required new strategies as a means to overcome the time-distance 
constraints of diffusion. Although variable in design, these strategies are invariably 
based upon internal transport and exchange systems that provide delivery of 
substances and removal of waste products to and from all cells in the body 
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(Monahan-Earley et al., 2013). These are called circulatory systems, and their 
complexity grew in parallel with that of organisms. In mammals, the circulatory 
system is a vascular system in which blood is propelled by the contraction of a 
muscular pump: the cardiovascular system. 
 
1.1. Functions	of	the	cardiovascular	system	
 
In addition to the already described role of transportation of nutrients, oxygen 
and metabolic waste products throughout the body, the cardiovascular system 
serves several other functions. As a transportation system, it also ensures the 
circulation of hormones and immune cells which allow respectively for long distance 
communication leading to whole body integration and for immune defence. 
Moreover, the cardiovascular system is not simply a passive conduit for blood and 
substances. Instead, it functions as a dynamic interface between the circulation and 
tissues. By adjusting vascular tone and cardiac output the amount of blood flowing to 
different organs and cells is adjusted to their energetic needs, as illustrated by the 
increased flood flow to the splanchnic, muscular or cerebral vasculature during 
digestion (Matheson et al., 2000), exercise (Joyner and Casey, 2015) or mental 
activities (Attwell et al., 2010). The regulation of blood flow also allows for body 
temperature control by adjusting skin perfusion, where heat can be dissipated. 
Finally, the cardiovascular system also performs important perfusion independent 
roles, as the instruction of development (Lammert et al., 2003) and regeneration of 
other organs (Ramasamy et al., 2015). 
 
Given the aforementioned, it is not surprising that the functioning of blood 
vessels directly impacts the health of every tissue and organ in the body. This is 
readily illustrated by the contribution of the vasculature to the pathogenesis of 
cardiovascular diseases and cancer, the two main mortality causes in western 
societies. Cardiovascular diseases are mostly secondary to the narrowing of blood 
vessels caused by atherosclerosis, which leads to tissue ischemia and loss of organ 
function. Moreover, insufficient reperfusion of injured organs caused by deficient 
formation of new blood vessels further maintains or aggravates the disease. Cancer, 
on the other hand, stimulates the formation of new blood vessels in order to supply 
its energetic demands and support its growth, and uses the vessel network to 
metastasize. Moreover, I would argue that due to the prevailing paradigm in western 
medicine that separates diseases into organ systems, the true impact of the 
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vasculature in the etiology and pathogenesis of most diseases has not been fully 
considered, questioned and investigated. Thus, understanding how blood vessels 
work holds enormous potential into understanding health and disease and improving 
human lives.  
 
1.2. Macroscopic	and	histological	organization	of	the	cardiovascular	system	
 
The concept that blood circulates in a closed loop propelled by the action of a 
centrally located pump was not established until the 17th century. Galen, the famous 
2nd century Greek physician, proposed that nutrient and oxygen rich blood constantly 
originated in the liver and in the heart, respectively, after which it travelled inside 
propelling blood vessels to all tissues in the body where it was consumed. This long-
standing view was challenged in 1628 by William Harvey, who by using observation 
and experimentation correctly described how blood circulates in a closed circuit from 
arteries to veins propelled by the beating of the heart. The link between arteries and 
veins, predicted by but elusive to Harvey, was finally closed by Marcello Malphighi in 
1661, who for the first time observed capillaries under a light microscope. These 
fundamental discoveries have laid the grounds to our current - more sophisticated 
yet still evolving - understanding of the cardiovascular system.  
 
Blood flows from the heart into arteries, which progressively branch into 
smaller arteries and arterioles until reaching capillaries, one-cell layered vessels 
where the diffusion of gases, nutrients and metabolic waste products takes place 
(Figure 1.1). From capillaries, blood returns to the heart through progressively larger 
venules and veins. Two separate but communicating blood vessels loops are 
recognised: the pulmonary and the systemic circulation. Deoxygenated blood is 
transported from the right heart to the lungs, where it is oxygenated in the lung 
capillaries before returning to the left heart – pulmonary circulation. From there, 
oxygenated blood is carried to all the other tissues of the body, finally returning to the 
right heart as deoxygenated blood – systemic circulation. It is in the systemic 
circulation that nutrients enter the blood (from the splanchnic and liver capillaries) 
and metabolic waste products are discarded from the blood (in the kidney 
capillaries). A complementary network of lymphatic vessels exists in close proximity 
to blood vessels, draining excess interstitial fluid back into the blood circulation. As 
this thesis is about particular aspects of the development of blood vessels, I will 
exclusively focus on the blood vessel network. 
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Figure 1.1. The vertebrate cardiovascular system 
The vertebrate cardiovascular system is a closed vascular system in which the blood is set in 
movement by the contractions of the heart. From the heart, blood is transported to all tissues through 
arteries and arterioles (distributing vessels), and returns to the heart in venules and veins (collecting 
vessels). Exchange of gases, nutrients and metabolic waste products takes place in capillaries. Image 
adapted from OpenStax, Anatomy & Physiology. OpenStax CNX. 
 
The functioning of the cardiovascular system is dependent on its hierarchical 
organization with vessels of different sizes and nature, which relate to their 
histological makeup. Capillaries, where exchange takes place, are composed of a 
single layer of endothelial cells (ECs) that provide a smooth contact surface with 
the blood, surrounded by a continuous basement membrane and by isolated 
pericytes. Arteries and veins, on the other hand, ensure the distribution and 
collection of blood. Arteries are exposed to high-pressure blood, and display thicker 
walls that include many layers of vascular smooth muscle cells and elastic fibres. 
Veins collect blood and return it to the heart, constituting a high capacity reservoir of 
low-pressure blood. Thus, veins have larger lumens and thinner walls in comparison 
to arteries, with fewer smooth muscle cells. A surrounding layer of connective tissue, 
mostly constituted by collagen fibres, supports and holds in place both arteries and 
veins. 
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2. Development	of	blood	vessels	
 
2.1. Vasculogenesis	and	angiogenesis	
 
The cardiovascular system is one of the first functional organ systems to 
develop in the vertebrate embryo. Soon after gastrulation, before the onset of a heart 
beat or blood circulation, individual mesoderm-derived endothelial precursor cells 
named angioblasts migrate, differentiate and coalesce into solid cords of cells that 
are subsequently lumenised forming patent vessels and networks. This process of de 
novo formation of blood vessels is referred to as vasculogenesis (Figure 1.2). It 
takes place only during early embryogenesis and leads to the formation of the major 
arteries and veins of the vertebrate embryo – which include the heart - as well as the 
formation of a primitive, homogeneous capillary network. Subsequently, this initial 
vessel network is expanded and remodelled into a highly stereotypical and 
hierarchical branched vessel network (where larger vessels ramify into smaller ones) 
covering the whole body. This occurs by a different process of blood vessel formation 
named angiogenesis, (Figure 1.2) a blood flow dependent process through which 
new blood vessels form from previously established ones. 
 
 
Figure 1.2. Blood vessel formation through vasculogenesis and angiogenesis 
During development, the first and major blood vessels or the organism are formed through 
vasculogenesis. Subsequently, this initial vasculature is expanded to the whole organisms through 
angiogenesis. 
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Angiogenesis is the process by which the vast majority of blood vessels are 
formed during development and growth. By the time adulthood is reached the 
vasculature is formed and ECs are in a state of quiescence. Little to no angiogenesis 
takes place. Nevertheless, the ability to turn angiogenesis on is maintained 
throughout the entire life. Angiogenesis happens in the adult during the physiological 
processes of female reproductive cycles and pregnancy, tissue repair and 
regeneration, and also during pathological processes such as the growth of solid 
tumours. Therefore, angiogenesis plays fundamental roles not only during embryonic 
development and growth into adult size, but also during adult homeostasis and 
disease. During the past decades, largely because of more sophisticated genetic 
tools, a boom of discoveries started to uncover the cellular and molecular 
mechanisms driving angiogenesis. 
 
2.2. Cellular	and	molecular	mechanisms	of	sprouting	angiogenesis	
 
Although more than one mechanism of angiogenesis has been described, the 
most frequent one is sprouting angiogenesis (Risau, 1997), a process by which 
new blood vessels sprout out of established vessels and form new vascular loops. It 
is a multi-step morphogenic process triggered by the release of pro-angiogenic 
factors from hypoxic tissues, which on binding to quiescent ECs cause their 
activation. ECs loosen their cell-cell contacts, acquire a migratory phenotype and re-
enter the cell cycle. Sprouts of ECs emerge from the parental vessel elongating 
towards the source of pro-angiogenic factors, and new vessel loops are formed by 
the fusion of neighbouring sprouts. As my thesis focuses on sprouting angiogenesis I 
will now present in more detail the cellular and molecular mechanisms driving this 
process. 
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Figure 1.3. The steps of sprouting angiogenesis 
Image adapted from (Potente et al., 2011). 
 
2.2.1. Hypoxia	and	the	release	of	pro-angiogenic	factors	
 
Sprouting angiogenesis is the appropriate response of the healthy 
vasculature to the presence of hypoxia – a state in which tissues do not receive 
enough oxygen to supply their metabolic needs. Hypoxia emerges as a result of 
increased oxygen demands or decreased oxygen delivery. Tissue growth increases 
the oxygen needs and drives angiogenesis during embryonic development and 
physiological growth, as well as during tumour growth. On the other hand, decreased 
oxygen delivery is caused by vascular dysfunction due to vessel narrowing, occlusion 
or rupture, and is for example the cause for the formation of collaterals during chronic 
heart ischemia. 
Cells adapt to oxygen levels by regulating the transcription of specific genes. 
Central to this mechanism are the transcription factors HIF (hypoxia-inducible 
factors), which are regulated by oxygen dependent enzymes (Krock et al., 2011). 
HIF-hydroxylases require molecular oxygen for their catalytic activity, and under 
normal oxygen levels, add hydroxyl groups to HIF-α subunits. This modification 
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causes HIF-α to be degraded by the proteasome, so that no transcriptional activity is 
performed. In contrast, under hypoxic conditions HIF-hydroxylases have no catalytic 
activity and do not modify HIF-α, which can bind to HIF-β making a functional 
transcriptional complex. In the nucleus, the HIF-α/HIF-β complex induces the 
expression of genes required for the cell’s adaptation to low oxygen levels. Among 
these are genes coding for pro-angiogenic molecules, such as vegfa, Angiopoetin-1, 
Angiopoetin-2, tie2, pdgf and fgf2. Hypoxic cells secrete pro-angiogenic molecules 
that bind to cell-surface receptors on ECs. This leads to their exit from the quiescent 
state and the start of sprouting of new vessels. The different factors play different 
roles during angiogenesis, which include all stages of the process from the initial 
breaking free from the parental vessel to the actual formation of new vessels and 
vessel maturation. 
 
2.2.2. Endothelial	 activation:	 degradation	of	 the	basement	membrane,	 detachment	
of	pericytes	and	loosening	of	cell-cell	junctions	
 
Quiescent ECs in mature vessels are enveloped in their basal side by a 
continuous layer of basement membrane composed of extracellular matrix (ECM) 
proteins. Embedded in the basement membrane are pericytes, mural cells that 
surround microvessels to different extents depending on the vascular bed (Armulik et 
al., 2011). Both the basement membrane and the pericytes give structural support to 
the vessel and contribute to the maintenance of endothelial quiescence – both 
physically and chemically, by means of cell signalling. Because of this, they impede 
the sprouting of ECs out of the parental vessels once activated. Therefore, the 
degradation of the basement membrane and the detachment of pericytes are 
required steps for ECs to exit quiescence. This takes place in response to pro-
angiogenic factors induced signalling in ECs. VEGF (vascular endothelial growth 
factor) and bFGF induce the expression, activation and secretion of matrix 
metalloproteinases (MMPs) that degrade the ECM proteins of the basement 
membrane, decreasing the physical barrier constraining ECs. Moreover, pro-
angiogenic signalling is promoted as previously inaccessible cell-surface receptors 
are exposed and pro-angiogenic factors previously bound to ECM proteins are 
released. Moreover, the adhesive junctions (tight and adherens junctions) that 
maintain ECs connected to their neighbours and regulate the permeability of the 
endothelium are loosened upon the sensing of pro-angiogenic factors, which allows 
for increased degrees of mobility of the individual cells. 
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2.2.3. Sprouting	
 
Once ECs are less constrained by physical barriers, a number of multicellular 
sprouts emerge from the parental vessel elongating in the direction of the hypoxic 
tissue. Individual cells within emerging sprouts show distinct phenotypes relating to 
their position (Gerhardt et al., 2003). The heading cells, named tip cells, are 
characterised by being highly migratory and invasive and by displaying numerous 
filopodia that probe the surrounding tissue for directional molecular cues (Gerhardt et 
al., 2003). Following cells, or stalk cells, trail behind the tip cells while maintaining 
the connection to the parental vessel, and contribute to the growth of the sprout by 
undergoing proliferation (Gerhardt et al., 2003, Dejana et al., 2009) and cell 
elongation (Sauteur et al., 2014). These morphological and behavioural differences 
between tip and stalk cells are accompanied by differences in gene expression 
(Gerhardt et al., 2003, Claxton and Fruttiger, 2004, Lu et al., 2004, Tammela et al., 
2008). Interestingly, the tip/stalk cell phenotype, initially thought to be unchangeable 
once specified, was later shown to be dynamic. The position of ECs in the sprout is 
not fixed in a head to tail fashion, but instead ECs can swap positions with their 
neighbours and the tip position can be overtaken by cells that were previously 
following (Jakobsson et al., 2010). 
  
The reason why neighbouring ECs respond to the same pro-angiogenic 
stimuli with different phenotypes lies in the mechanism of lateral inhibition. This 
mechanism is at the core of the Notch signalling pathway, which is extremely 
important in morphogenesis as it allows for the emergence of heterogeneity in a 
homogenous population of contacting cells (Lai, 2004). In ECs, the specification of 
tip/stalk phenotypes involves the cooperation of the Notch and the VEGF signalling 
pathways. The binding of VEGF to its cell-surface receptor in ECs leads to the 
transcription of genes that confer to that cell a tip phenotype. Among those genes is 
dll4. DLL4 is a transmembrane receptor of the Notch signalling pathway that binds 
the extracellular domain of the NOTCH1 protein in a neighbouring, contacting cell. 
This binding promotes the cleavage of the NOTCH1 protein and the release to the 
cytoplasm of the Notch intracellular domain (NICD). NICD translocates to the nucleus 
where it drives the transcription of Notch target genes that confer to that cell a stalk 
phenotype while supressing the tip phenotype. The latter is achieved by a decrease 
in sensitivity to VEGF caused by downregulation of the VEGF receptor and 
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upregulation of a decoy receptor for VEGF (that binds to the ligand without inducing 
downstream signalling, thus acting as an inhibitor). In summary, high VEGF 
signalling “makes” tip cells while high Notch signalling “makes” stalk cells, and “tip” 
cells inhibit neighbouring cells from also acquiring a tip phenotype. The specification 
of tip/stalk phenotypes here described is highly simplified, and many more layers of 
regulation exist that allow for the precise control of tip/stalk cell numbers and for their 
dynamic regulations. 
 
2.2.4. Anastomosis	and	formation	of	new	loops	
 
In addition to their role in sensing molecular cues and guiding cell migration, 
filopodia in tip cells carry cell-cell junction molecules that recognise filopodia in the tip 
cells of neighbouring sprouts (Lenard et al., 2013). This is the first step in the fusion 
of sprouts leading to the formation of new vascular loops. While the initial contacts 
between neighbouring filopodia are unstable and short lived (Lenard et al., 2013), 
this is followed by the establishment of stable cell-cell junctions initially between 
filopodia and later involving the cell body. The migration and rearrangement of the 
contacting tip cells further causes the elongation of the cell-cell junction. A de novo 
lumen opens between the cell-cell junctions, while the lumens of both sprouts 
expand in the direction of the connection. Finally, the lumens connect and the new 
vascular loop is perfused and connected to the circulation of the plexus.  
 
2.2.5. Formation	of	a	vascular	lumen	
 
The formation of a continuous lumen is a critical step in forming functional, 
perfusable blood vessels. The initial model of lumen formation in blood vessels 
derived from observations of 3D cultured ECs (Davis and Bayless, 2003) and of 
blood vessels undergoing lumenisation in live zebrafish embryos (Kamei et al., 
2006). These experiments proposed that the lumen in blood vessels arises from the 
formation and coalescence of intracellular vesicles in single cells, which than fuse 
with the lumens of neighbouring cells. More recently, the increase in time and space 
resolution during live imaging in the zebrafish embryo contradicted the previous 
model and showed that lumens in ECs form already in tip cells by inverse blebbing of 
the luminal membrane (Gebala et al., 2016). This mechanism is blood flow 
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dependent and involves a tight balance between flow-induced pressure pushing the 
lumen into the cell, and the response of the cell’s actomyosin cytoskeleton. 
 
2.2.6. Vessel	maturation	
 
The formation of a new functional vasculature requires final steps that ensure 
the stabilisation of blood vessels. Cell-cell junctions become more stable. ECs 
produce and deposit ECM proteins forming a continuous basement membrane that 
provides structural support for the vessel and promotes endothelial quiescence. 
Finally, mural cells are recruited to the vessels wall, also providing structural and 
signalling functions that help maintaining the vessel.  
 
2.2.7. Vessel	remodelling	
 
Sprouting angiogenesis leads at first to the establishment of a primitive 
plexus in which an excess of vascular loops is present. With time, this primitive 
plexus is extensively remodelled into a more mature, hierarchically branched and 
functional network ideally suited to accommodate the metabolic demands of the 
tissue in the most efficient way. Critically, what happens during this process is the 
regression (or pruning) of a number of superfluous vessel segments. The 
mechanisms behind vessel regression are likely dependent on the vascular bed in 
case. In vascular networks that completely regress during development endothelial 
apoptosis plays a role in this process (Lobov et al., 2005, Meeson et al., 1999). 
However, the mechanism of vessel regression in vascular beds that persist does not 
rely on apoptosis but on endothelial migration and rearrangements in response to 
blood flow, in a cellular mechanism reminiscent of anastomosis in reverse (Franco et 
al., 2015). While vessel segments experiencing high blood flow are reinforced, those 
experiencing low blood flow are more likely to regress. While this explains how blood 
flow shapes the development of a more mature vasculature, it does not explain why 
some low flow segments are kept. Interestingly, recent work (Vion et al., 2018) 
showed that the endothelial primary cilia prevent the regression of low flow 
segments, thus proposing a mechanism in which ECs autonomously balance the 
effect of blood flow towards the achievement of a mature, functional network.  
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2.2.8. Specification	of	arteries	and	veins	
 
The establishment of separate but interconnected arterial and venous vessel 
networks is imperative for the functioning of the cardiovascular system as a closed 
loop. Thus, it is critical that during the maturation of the vasculature immature 
vessels are specified into arteries or veins.  
While arteries transport high speed and pressure blood from the heart to 
capillaries, veins carry the blood back to the heart in low speed and pressure 
conditions, and in most cases against gravity. These differences are appropriately 
reflected by the distinct structure of their walls. Arteries have thick and elastic walls 
with numerous layers of vascular smooth muscle and elastin fibers. Veins, on the 
other hand, have relatively thin walls with less smooth muscle and bear valves that 
help maintaining the unidirectionality of blood flow. In addition to the functional and 
morphological differences, arteries and veins also show molecular differences, the 
first identified being the ligand ephrin-B2 marking arteries and its receptor Eph-B4 
marking veins (Wang et al., 1998). 
The mechanism underlying the acquisition of an arterial or venous identity 
has for long been a subject of debate in vascular biology. It was initially thought that 
the hemodynamics of blood flow played a determinant role, as vessels are subjected 
to different speeds, pressure and directionality of flow depending on their position in 
the plexus. However, the fact that the major arteries and veins of the embryo are 
formed before the onset of a heartbeat and blood flow led to the idea of artery-
venous identity being genetically programmed (Swift and Weinstein, 2009). Grafting 
experiments in avian embryos have shown that the identity of ECs as arterial or 
venous is plastic and can be reversed (Moyon et al., 2001, Othman-Hassan et al., 
2001), suggesting that local cues instead of a genetic pre-programming drive arterial-
venous identity. Soon after that, manipulation of blood flow in avian embryos proved 
able to regulate arterial-venous differentiation and expression of arterial-venous 
markers (le Noble et al., 2004), supporting the view that hemodynamic forces are 
instrumental in the specification of arteries and veins. Still, strong evidence supports 
a model in which the specification of arteries and veins is molecularly determined. 
Notch activity has been shown to promote arterial fate (Zhong et al., 2001, Lawson et 
al., 2001, Lawson et al., 2002, Geudens et al., 2010), while COUP-TFII, a 
transcription factor, induces venous specification (You et al., 2005). Unpublished 
data (Geudens et al., 2018) suggest that both mechanisms may in fact be correct 
and complementary, with blood flow being able to change the fate of arteries and 
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veins that are primarily molecularly predetermined, to ensure a correct balance 
between arteries and veins. 
 
 
3. The	mouse	retina	model	of	angiogenesis	
 
The current understanding of the mechanisms driving sprouting angiogenesis 
is largely derived from observation and experimentation in animal models. Of the 
many available models, the vascularization of the mouse retina is one of the most 
widely used. 
 
Unlike most tissues that are vascularized during embryonic development, the 
vascularization of the mouse retina only starts at birth. The complete retina 
vasculature consists of three parallel layers of blood vessels that develop from birth 
until around the 3rd week of live. The first layer to be developed, the superficial layer, 
grows radially over the inner surface of the retina from the optic disc to the periphery 
of the retina, reaching the outer limit of the tissue at the end of the first week of life. 
After that, new vessels sprout downward from the superficial layer and invade the 
retina, forming the intermediate and deeper layers. Mostly, angiogenesis studies 
focus on the development of the superficial layer of the mouse retina vasculature. 
 
Many advantages account for the popularity of this model. Because the retina 
vasculature develops post-natally, its spares the need to collect mouse embryos, 
which translates into fewer used animals. Technically, the retina is relatively easy to 
handle, and its structure and shape make it suitable for whole-mount 
immunostaining. The superficial layer of the vasculature develops in a highly 
stereotypical and robust manner. Moreover, the vessels are arranged in two 
dimensions in close proximity to the surface of the tissue, allowing for high-resolution 
imaging. In addition, the same sample allows for the observation of ECs undergoing 
different steps of the angiogenesis process: while ECs are sprouting new blood 
vessels at the periphery of the retina, in the center blood vessels undergo remodeling 
and arteries and veins can be distinguished. Finally, the model benefits from 
sophisticated genetic tools available for the mouse. In particular, cell-specific and 
time controlled gene deletion technology enables the study of cell autonomous gene 
requirements during the development of the retina vasculature without affecting the 
development of blood vessels embryonically.  
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As such, the mouse retina model is an excellent tool to uncover the role of a 
variety of genes during different steps of the vascularization process.  
 
Figure 1.4. The mouse retina model of angiogenesis 
A whole flat mounted retina from a P6 mouse, stained for blood vessels. The blood vessels 
correspond to the developing superficial layer of the vasculature. In the same preparation different steps 
of the angiogenesis process can be observed. 
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2. PART	2:	YAP	and	TAZ	
 
The past decades have uncovered many of the fundamental principles of 
sprouting angiogenesis, at the cellular and molecular level. Various signalling 
pathways regulating angiogenesis were discovered, and anti and pro-angiogenic 
molecules identified and applied in the clinical setting with a few successes. 
However, in the majority of cases the reality of angiogenic therapies eluded 
expectations, showcasing the need to understand in greater depth how this process 
works. In the meantime, a relatively new signalling pathway, the Hippo pathway, 
generated a lot of excitement in the developmental biology and cancer research 
fields. The final effectors of the Hippo pathway, the transcriptional co-activators YAP 
(Yes – associated protein) and TAZ (transcriptional co-activator with PDZ-binding 
motif), were shown to critically control many aspects of cell biology such as 
proliferation, apoptosis, migration and invasiveness. At the same time, multiple inputs 
regulating their activity were identified, not only of a chemical nature but interestingly 
also mechanical. This placed YAP and TAZ in the centre of a novel and complex 
intracellular hub for cell decisions. Sprouting angiogenesis requires the coordination 
of cell proliferation, apoptosis, migration and invasiveness, during which ECs 
integrate and are instructed by multiple cues from the environment, including 
mechanical signals from the flowing of blood. These reasons made YAP and TAZ 
very interesting candidates to investigate during sprouting angiogenesis, the more so 
that their role in ECs and vessels was virtually unknown at the start of this project. 
 
1. YAP,	TAZ	and	the	Hippo	pathway	
 
YAP and TAZ (also known as WW domain containing transcription regulator 
1, WWTR1) are two homologous transcriptional co-activators firstly identified as the 
final effectors of the mammalian Hippo signaling pathway, a highly conserved kinase 
cascade discovered as a master regulator of organ size (Huang et al., 2005, Dong et 
al., 2007). At its core, the Hippo pathway is a phosphorylation cascade comprising 
two kinases – MST and LATS – that inactivate the pro-growth transcriptional co-
activators YAP and TAZ (Yu et al., 2015). Upon activation by upstream stimuli, MST 
phosphorylates and activates LATS, which then phosphorylates YAP and TAZ 
leading to their cytoplasmic retention (Kanai et al., 2000, Basu et al., 2003) and 
degradation (Liu et al., 2010, Zhao et al., 2010). When Hippo is not active, YAP and 
TAZ are not phosphorylated by LATS and are thus able to translocate to the nucleus 
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where, through cooperation with transcription factors, they increase the expression of 
pro-proliferation and anti-apoptosis genes(Yu et al., 2015) (Figure 1.5).  
 
2. Upstream	stimuli	feeding	into	the	Hippo	pathway:	from	a	kinase	cascade	to	a	complex	
signalling	network		
 
Since the discovery of the core components of the Hippo pathway a wide 
range of upstream regulators has been searched and identified (Figure 1.5). G-
protein coupled membrane receptors (Yu et al., 2012, Miller et al., 2012, Mo et al., 
2012), cell-cell junctions (Kim et al., 2011, Silvis et al., 2011, Schlegelmilch et al., 
2011), apical-basal polarity complexes (Chen et al., 2010, Ling et al., 2010, 
Baumgartner et al., 2010, Genevet et al., 2010, Yu et al., 2010, Grzeschik et al., 
2010, Hamaratoglu et al., 2006), planar cell-polarity complexes and cell-matrix 
interactions proteins (Elbediwy et al., 2016) all have been shown to regulate the 
Hippo pathway. Interestingly, to this extensive list of chemical inputs, also 
mechanical stimuli have been added. The location and activity of YAP and TAZ was 
shown to be sensitive to cell geometry and shape, ECM stiffness, intracellular 
tension dependent on actomyosin contraction, changes in the actin cytoskeleton and 
RhoGTPases (Dupont et al., 2011, Wada et al., 2011, Zhao et al., 2012). 
 
In addition, further research evidenced that the Hippo pathway shows 
significant crosstalk with other signalling pathways, in a tissue and context depend 
manner, adding yet another layer of complexity to the kinase cascade. This 
intertwining of pathways has been observed with Wnt (Varelas et al., 2010, Heallen 
et al., 2011, Azzolin et al., 2012, Azzolin et al., 2014), Shh (Fernandez et al., 2009), 
TGF-β/BMP (Fujii et al., 2012, Beyer et al., 2013) and Notch signalling pathways 
(Totaro et al., 2017). 
 
Finally, YAP and TAZ can also be directly regulated by LATS independent 
mechanisms (Dupont et al., 2011, Miller et al., 2012), which led some authors to 
suggest the terms canonical (through the kinase cascade) and non-canonical Hippo 
pathway. Regardless of the nomenclature, what has become clear is that unlike a 
conventional signal transduction pathway with dedicated receptors and molecules, 
the Hippo pathway is instead a complex signalling network, and YAP and TAZ a hub 
for cellular decision-making. 
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Figure 1.5. Regulation of YAP/TAZ 
YAP/TAZ are regulated by several mechanisms. The phosphorylation of YAP/TAZ by the 
Hippo kinases MST1/2 and LATS1/2 leads to cytoplasmic retention and proteasomal degradation, 
impeding the binding to transcription factors in the nucleus. In addition to the Hippo kinases, YAP/TAZ 
are also regulated by cell-matrix contacts, GPCRs, cell-cell contacts, polarity complexus and 
cytoskeletal contractility. When YAP/TAZ are not phosphorylated they accumulate in the nucleus where 
they bind to transcription factors (as the TEAD family of transcription factors), resulting in transcription of 
target genes.  
 
3. Downstream	functions	of	the	Hippo	pathway		
 
The discovery of the Hippo pathway took place during forward genetic 
screens in the fruit fly looking for tumor suppressor genes. There, the loss of the 
Hippo core kinases led to dramatic overgrowth phenotypes (Xu et al., 1995, Justice 
et al., 1995, Harvey et al., 2003, Jia et al., 2003, Pantalacci et al., 2003, Udan et al., 
2003, Wu et al., 2003). Because of this, the first identified role of the Hippo pathway 
was that of controlling organ size through the regulation of cell proliferation and 
apoptosis. The Hippo pathway became recognized as the molecular mechanism 
explaining the phenomenon of contact inhibition of proliferation in epithelial tissues. 
Although this is also true for some mammalian tissues, some authors argue that the 
regulation of entry and exit from the cell cycle might be more relevant than organ size 
control in mammals (Halder and Johnson, 2011). Since these initial observations, an 
Introduction 
36 
abundance of data has attributed other critical functions to the Hippo pathway. The 
Hippo pathway was shown to regulate the maintenance and differentiation of stem 
cells (Ramos and Camargo, 2012, Hiemer and Varelas, 2013), cell migration, 
epithelial-mesenchymal transition (EMT) (Harvey et al., 2013, Moroishi et al., 2015, 
Yu et al., 2015), contractility and force generation(Lin et al., 2017) and even cell and 
body metabolism (Ardestani et al., 2018).  
 
Because of described functions, the Hippo pathway plays fundamental roles 
during development, regeneration and homeostasis. Aberrant activation of YAP and 
TAZ has been extensively associated with increased cancer formation and 
aggressiveness, while inactivation of YAP and TAZ impairs tissue development, 
regeneration and maintenance of stem cell pools (Fu et al., 2017). 
 
Molecularly, the Hippo pathway controls such cellular functions by regulating 
gene expression. Although YAP and TAZ lack DNA binding domains, they act as 
transcriptional co-activators by binding and promoting the activity of transcription 
factors once in the nucleus. The TEAD family of transcription factors, TEAD 1-4, are 
the best-known DNA partners of YAP and TAZ and mediate many of the described 
functions of the Hippo pathway (Vassilev et al., 2001, Zhang et al., 2009). In addition 
to TEAD, YAP and TAZ also interact with several other transcription factors such as 
the RUNX family of transcription factors (Passaniti et al., 2017) and p73 (Lapi et al., 
2008). Importantly, although some common genes are regulated by YAP and TAZ 
throughout a wide number of cells, and thus considered as indicators for YAP and 
TAZ activity (as Ctgf, Cyr61 and Ankrd1), most target genes are cell specific, 
emphasizing that the role of YAP and TAZ is highly cell context dependent (Halder 
and Johnson, 2011).  
 
4. Similarities	and	differences	between	YAP	and	TAZ	
 
While YAP orthologs are present from the earliest animal forms (Yorkie being 
the Drosophila YAP ortholog), TAZ proteins are only found in vertebrates. TAZ 
represent a late evolutionary novelty, and sequence analysis suggests that the Taz 
gene probably originated from gene duplication of Yap in early vertebrates (Hilman 
and Gat, 2011). With almost 50% amino acid identity, YAP and TAZ share many 
regulatory and structural domains, and bind similar proteins and transcription factors. 
However, the use of Yap and Taz knockout (KO) animals has revealed different in 
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vivo functions for both proteins. While the knockout of Yap leads to embryonic 
lethality around embryonic day 8.5 (Morin-Kensicki et al., 2006), Taz KO mice 
survive until adulthood but develop lung and kidney disease (Makita et al., 2008, 
Hossain et al., 2007). At the same time, the deletion of both Yap and Taz led to much 
earlier embryonic lethality, with embryos dying before the morula stage (Nishioka et 
al., 2009), which showcases a degree of redundancy between both proteins. While 
many cellular functions seem to be shared, the relative requirement of different 
tissues and organs for YAP and TAZ may differ, and the same is true for time 
sensitive demands throughout development, homeostasis and response to disease. 
Having said that, understanding the unique and redundant roles of YAP and TAZ will 
benefit from the use of tissue and cell specific genetic manipulation in vivo.  
 
 
Figure 1.6: Amino acid structure of YAP and TAZ  
YAP and TAZ are paralog proteins that share around 50% amino acid similarity, including 
many structural domains and regulatory regions. Both proteins display a transcription factor-binding 
domain that binds the TEAD family of transcription factors; two (YAP) or one (TAZ) WW domains that 
bind PPXY-containing transcriptional factors and are required for the interaction with LATS kinases; a 
transcription activation domain; and a PDZ binding domain that mediates the localization of YAP and 
TAZ to discrete nuclear foci, to the cell membrane or to the cytoskeleton. YAP and TAZ also have 
several serine residues that, upon being phosphorylated by LATS, mediate proteasome degradation or 
binding to 14-3-3 proteins leading to cytosol sequestration. 
 
5. Yap	and	Taz	in	vascular	biology	
 
The first suggestion that the Hippo pathway was required for blood vessel 
formation came from the full deletion of Yap in mice. Among other critical defects that 
lead to developmental arrest, these embryos present defects in the vascularisation of 
the yolk sac (Morin-Kensicki et al., 2006). Later, an endothelial-specific deletion of 
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Yap in mice was generated using the constitutional Tie2-Cre transgenic line, which 
also targets endocardial cells. There, fatal heart valve defects caused by failed 
endothelial-mesenchymal transition (EndoMT) precluded the analysis of the blood 
flow dependent process of angiogenesis (Zhang et al., 2014). In a different study 
using small interfering RNAs (siRNAs) to decrease the expression of YAP in the 
post-natal mouse retina, YAP was shown to regulate vascular branching and density 
by promoting the transcription of Angiopoetin-2 (Choi et al., 2015). While this study 
suggested an important effect during angiogenesis, the cell autonomous role of YAP 
could not be appreciated, as other cells could contribute to the phenotype. In the 
zebrafish, Yap mutants develop an initially normal vasculature but display increased 
vessel collapse and regression, suggesting a role for YAP during the maintenance of 
blood vessels. In contrast, Yap/Taz double mutant zebrafish fail to form the dorsal 
aorta and post cardinal vein (which are formed through vasculogenesis) and die 
before the onset of circulation with other severe developmental defects (Nakajima et 
al., 2017).  
  
The cellular functions and molecular regulation of YAP and TAZ in ECs was 
also investigated using cell culture assays and live imaging in zebrafish embryos. A 
pro-proliferation effect of YAP on ECs was reported by some (Shen and Stanger, 
2015), but not all (Choi et al., 2015) groups. In contrast, YAP was consistently found 
not to affect apoptosis in ECs (Shen and Stanger, 2015, Choi et al., 2015). While 
these initial studies did not extensively address the roles of endothelial YAP and 
TAZ, they did point towards important regulation of YAP in ECs. Similarly to other cell 
types, endothelial YAP is regulated by cell-cell contacts, specifically by the 
endothelial adherens junction molecule VE-Cadherin. Moreover, endothelial YAP 
was shown to sense blood flow (Wang et al., 2016, Nakajima et al., 2017).  
   
While these studies suggest that YAP affects endothelial biology and plays a 
role during the formation of blood vessels, detailed analysis on the role of YAP and 
TAZ during developmental sprouting angiogenesis is missing. Likewise, the cellular 
functions of YAP and TAZ, their effectors and interplay with other relevant signalling 
pathways in ECs remain poorly understood. 
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3. PART	3:	Project	questions	and	aims	
 
The recently discovered Hippo pathway has quickly gained its place in the 
restricted group of signalling pathways critically important for development. With 
reports suggesting that the Hippo pathway is required during vessel formation, a 
detailed picture of the cellular and molecular functions of endothelial YAP and TAZ is 
still missing. In this context, the aim of my project is to understand the role of YAP 
and TAZ in ECs during developmental sprouting angiogenesis. For that, I have 
focused on 3 main questions: 
 
Are endothelial YAP and TAZ required for sprouting angiogenesis in vivo? 
(Chapter 3) 
 
What are the cellular functions of YAP and TAZ in ECs? (Chapter 4) 
 
What are the molecular mechanisms mediating the functions of YAP and TAZ 
in ECs? (Chapter 5) 
 
To address these questions I took advantage of the mouse retina model of 
sprouting angiogenesis coupled with cell-specific inducible loss-of-function genetic 
tools. In addition, I complemented these techniques with in vitro culture of ECs to 
dissect specific cellular and molecular questions.  
 
Having introduced the necessary background information in this chapter, I will 
in chapter 2 describe in detail the material and methods used. In chapters 3, 4 and 5 
I will present my results: in chapter 3 I describe the phenotype of Yap and Taz 
endothelial cell mutants; in chapter 4 I present the cellular functions of endothelial 
YAP and TAZ in vitro and in vivo; in chapter 5 I show how YAP and TAZ affect 
endothelial behaviour by regulating BMP signalling. Finally, in chapter 6 I conclude 
the thesis by discussing my results and present future perspectives.  
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Chapter	2:	Material	and	Methods	
 
1. Mice	and	treatments	
 
For loss of function experiments the following mouse strains were used: Yap 
fl/fl, Taz fl/fl (Gruber et al., 2016) and Pdgfb-iCreERT2 (Claxton et al., 2008). Mice were 
maintained at the London Research Institute and at the Max Delbruck Center for 
Molecular Medicine under standard husbandry conditions. To induce Cre-mediated 
recombination 4-hydroxytamoxifen (Sigma, 7904) was injected intraperitoneally (IP) 
(20 µL/g of 1 mg/mL solution) at postnatal day 1 (P1) and day 3 (P3) and eyes were 
collected at P6. In all experiments control animals were littermate animals without 
Cre expression. Male and female mice were used for the analysis.  
For EC proliferation assessment in the retina, mouse pups were injected IP 
2 hours before culling with 20 uL/g of EdU solution (5-ethynyl-2'-deoxyuridine)(0.5 
mg/mL; Thermo Fischer Scientific, C10340).  
 
 
2. Cell	culture	
 
Human umbilical vein endothelial cells (HUVECs) from pooled donors 
(PromoCell) were cultured in EGM2-Bulletkit without antibiotics (Lonza) and used 
until passage 6. The manufacturers authenticated the identity of HUVECs by flow 
cytometry for cell-type specific markers (vWF, CD31, CD105) and by functional 
analysis (cells positive for acetylated low density lipoprotein uptake). All cells were 
tested negative for mycoplasma.  
 
For knockdown experiments, HUVECs were transfected with SMARTpool: 
siGENOME siRNAs purchased from Dharmacon (Yap #M-012200-00-0005, Taz #M-
016083-00-0005, VE-Cadherin #M-003641-01-0005 and non-targeting siRNA Pool 1 
#D001206-13-05). Briefly, subconfluent (70-80%) HUVECs were transfected with 25 
nM siRNA using Dharmafect 1 transfection reagent following the protocol from the 
manufacturer; transfection media was removed after 24h and experiments were 
routinely performed on the third day after transfection. 
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3. Immunofluorescence	staining	
 
3.1. Immunofluorescence	in	the	mouse	retina	
 
Pups were culled by decapitation at P6, and eyes collected and fixed in 4% 
PFA in PBS for 1h at 4C. Retinas were dissected in PBS under a stereomicroscope. 
After that, retinas were permeabilised/ blocked for 1h at room temperature in 1% 
BSA, 2% FBS, 0.5% Triton X100, 0.01% Na deoxycholate and 0,02% Na Azide in 
PBS. Primary and secondary antibodies were incubated overnight at 4C and for 2h at 
room temperature, respectively, both in 1:1 PBS: blocking buffer. Isolectin staining 
was performed overnight at 4C in Pblec after retinas were equilibrated for 1h in Pblec 
at room temperature. Retinas were post-stained fixed in 2% PFA in PBS for 10 
minutes. To mount the samples Vectashield mounting medium. (Vector Labs, H1000) 
or ProLong Gold (Thermo Fisher Scientific) was used. Imaging was done by laser 
scanning confocal microscopy (Carl Zeiss LSM700, LSM780 and Leica TCS SP8). 
Processing of samples was carried out in tissues from littermates under the same 
conditions. A list of the antibodies used can be found in Table 1. 
 
3.2. Immunofluorescence	in	HUVECs	
 
HUVECs were grown in #1.5 coverslips coated with poly-lysine and gelatin 
0.2%. At the end of the experiment cells were fixed in 4% PFA for 10min, 
permeabilised in 0.3% Triton-X100 in blocking buffer for 5min and blocked in 1% 
BSA 20mM Glycine in PBS for 30 min. Primary and secondary antibodies were 
incubated for 2 and 1 hours, respectively, in blocking buffer. Nuclei labeling was 
performed by incubating cells with DAPI for 5 min (Life technologies, D1306). A list of 
the antibodies used can be found in Table 1. 
 
 Reference Dilution Company  
Yap 46189 1:100 ThermoFisher 
Scientific 
Retinas + 
HUVECs 
Taz HPA007415 1:100 Sigma Retinas + 
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HUVECs 
Erg sc-18136 1:100 Santa Cruz 
Biotechnology 
Retinas 
Erg Ab92513 1:1000 Abcam Retinas 
VE-Cadherin 555289 1:100 BD Biosciences Retinas 
TER-119 MAB1125 1:100 R&D Systems Retinas 
PECAM-1 AF3628 1:200 R&D Systems Retinas 
Cleaved 
Caspase 3 
AF835 1:200 R&D Systems Retinas 
Dll4 AF1389 1:100 R&D Systems Retinas 
pSMAD1/5/8 13820S 1:1000 Cell Signalling Retinas 
Phalloidin- Alexa-
Fluor 488 
A12379 1:100 ThermoFisher 
Scientific 
HUVECs 
Ib4-Alexa-Fluor 
647 Conjugate 
I32450 1:1000 ThermoFisher 
Scientific 
Retinas + 
HUVECs 
Ib4-Alexa-Fluor 
488 Conjugate 
I21411 1:1000 ThermoFisher 
Scientific 
Retinas + 
HUVECs 
Ib4-Alexa-Fluor 
568 Conjugate 
I21412 1:1000 ThermoFisher 
Scientific 
Retinas + 
HUVECs 
 
Table 1. Antibodies and dyes used. 
 
 
4. Image	analysis		
 
4.1. Image	analysis	of	retinal	parameters	
 
Analysis of radial expansion, capillary density, branching frequency, 
endothelial proliferation, apoptosis and sprouting numbers was done using Fiji 
(Schindelin et al., 2012). Radial expansion corresponds to the mean distance from 
the optic nerve to the sprouting front (8 measurements in tilescans of two whole 
retinas per animal). Capillary density corresponds to the vessel area (measured by 
thresholding IB4 signal) divided by the field of view area (6–8 images of (425 mm)2 
between artery and vein per animal). Branching frequency was measured by 
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manually counting all branching points in a field of view (4-5 images of (200 mm)2 
between artery and vein per animal). The plexus regularity was assessed through 
the standard deviation of the size and the circularity of the vascular loops in the 
plexus (using same images as for analysis of capillary density). Vascular loops were 
segmented by thresholding the IB4 signal, and in order to avoid artifacts loops with a 
size smaller than 86 um^2 were excluded from analysis. Endothelial proliferation 
was measured by manually counting the number of EdU positive endothelial nuclei 
(ERG positive) and dividing by the vessel area (measured by thresholding IB4 signal) 
(4 images of (425 mm)2 containing the sprouting front and localized on top of arteries 
per animal). Apoptosis was measured manually by counting the number of cleaved 
caspase 3 positive figures and dividing by the vessel area (measured by thresholding 
IB4 signal) (tilescan of one whole retina per animal). The number of sprouts was 
measured manually (3 images of 425x850mm of the sprouting front per animal). To 
quantify pSMAD1/5/8 status the number of pSMAD1/5/8 positive endothelial nuclei 
was manually counted and dividing by the total number of endothelial nuclei (defined 
by being ERG positive) (3 images of (225mm)2 containing the sprouting front were 
used per animal). 
 
4.2. Image	analysis	in	cell	culture	experiments	
 
To analyse YAP/TAZ subcellular localisation in HUVECs a previously 
existing cytoplasm-to-nucleus translocation assay pipeline from Cell Profiler 
(Carpenter et al., 2006) was adapted. Briefly, YAP or TAZ staining intensity was 
measured both inside the nucleus of the cell and in a 12 pixels wide ring of 
cytoplasm grown radially from the nucleus. The nucleus localisation was determined 
using a DAPI mask.  
 
Cell junction morphology analysis was done in confluent monolayers of 
HUVECs stained for VE-Cadherin. 5 morphological categories were defined: straight, 
thick, thick to reticular, reticular and fingers. 5 images of (160mm)2 were acquired per 
condition per experiment. Each image was divided in (16 mm)2 patches, and patches 
were randomly grouped using a script written by Dr. Silvanus Alt. The classification 
into categories was done manually and blindly for the condition.  
 
To analyse cell coordination confluent cells labelled for DAPI were used. 
The nuclei were automatically segmented using a customized Python algorithm 
Material and Methods 
 
44 
relying on the Scikit Image Library written by Dr. Silvanus Alt. By fitting an ellipse to 
each nucleus its major and minor axis were obtained, and the angle of the major axis 
with the x-axis of the image was assigned to the nucleus as its orientation. This way 
each nucleus in the images was assigned a position given by its midpoint and an 
orientation. Next,  the average alignment of the nuclei of two cells depending on their 
distance was analyzed. As the nuclei don not have a directionality (i.e. they are 
nematics as opposed to vectors), the angles between two nuclei range from 0 
corresponding to the nuclei being parallel, to !/2 corresponding to them spanning a 
right angle. For any two cells in each image the angle and the Euclidean distance 
between them were calculated, and then the cells were binned depending on their 
distance. A parameter called 'alignment' was defined in which 1 corresponded to all 
cells being perfectly aligned and 0 corresponded to a completely random distribution 
of cell orientations.  
 
 
5. VEGF	treatment	experiments		
 
5.1. VEGF	treatment	and	YAP/TAZ	staining	
 
Confluent HUVECs were maintained in VEGF free media for 24h. VEGF 
treatment was then performed for 30 min, 1h and 3h with 0 or 40ng/mL of VEGF-165 
(PrepoTech, 450-32). Immunofluorescence staining and analysis of YAP and TAZ 
subcellular localisation was performed as above described. 
 
5.2. VEGF	treatment	and	proliferation	assessment	
 
Knockdown HUVECs were maintained in VEGF free media for 24h. VEGF 
treatment was then performed for 24h with 0ng/mL, 40ng/mL, 200ng/mL or 
1000ng/mL of VEGF-165. Cells were pelleted, ressuspended in 90% cold Methanol 
and stored at -20C° before further processing. Cells were then ressuspended in 
Propidium Iodide/RNase staining solution (Cell signaling, 4087) for 30 minutes before 
cell cycle analysis by flow cytometry (LSRII, BD). Data was analysed using BD 
FACSDiva™ software. 
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6. Mechanical	stretch	experiments	and	proliferation	assessment		
 
HUVECs were plated on collagen I - 0.2% gelatine-coated Bioflex plates (BF-
3001C, Flexcell International Corporation). Gene knockdown was preformed as 
previously described. Cells were incubated in transfection media for 24h, and 
allowed to recover in fresh complete media for 4h. Afterwards cells were incubated 
for 24h in serum starvation media (0,1%BSA in EBM2 pure media) to form a 
confluent, quiescent monolayer. Cyclic stretch (0.25Hz, 15% elongation) was then 
applied for 24h using a Flexcell® FX-5000™ Tension System. Control cells were 
placed in the same incubator but not on the Flexcell® device (static conditions). EdU 
pulsing was performed after 20h of the 24h stretch period. At the end of the 
experiment cells were fixed in 4% PFA and EdU staining was performed according to 
the manufacturer’s protocol (Click-It EdU C10340 Life Technologies). Nuclei were 
labelled with DAPI. Three regions of interested were acquired per sample in a Carl 
Zeiss LSM700 scanning confocal microscopes (Zeiss, Germany). Quantification of 
proliferation was done using a CellProfiler pipeline. Percentage of S phase cells was 
determined as percentage of EdU positive nuclei over the total number of nuclei. 
 
 
7. Assays	 on	 cells	 to	 investigate	 adherens	 junctions	 function	 and	
morphology	
 
7.1. Permeability	assay		
 
24h after siRNA transfection cells were re-plated into fibronectin coated 
Transwell® membranes (Costar 3460) at confluence and incubated for 2 more days 
to stabilize cell junctions. On the third day after transfection 0.5mg/mL of 250kDa 
FITC Dextran in cell media (Sigma FD250) was added to the top well. Fluorescence 
on the bottom well was measured after 6h in a Gemini XPS fluorescent plate reader.  
 
7.2. Pulse	chase	VE-Cadherin	experiment	 for	quantification	of	 low,	 intermediate	and	
high turnover	junctions		
 
 Cells were labelled live with a non-blocking monoclonal antibody 
directed against extracellular VE-Cadherin and directly coupled with Alexa-Fluor647 
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(BD Pharmingen, #561567, 1:200) for 30 minutes. Cells were then washed 2x with 
PBS and incubated with complete media for additional 2 hours. Cells were fixed with 
4% PFA and stained for VE-Cadherin (Santa Cruz Biotechnology, #6458, 1:200) with 
a secondary antibody coupled with Alexa-Fluor-488. 5 (160mm)2 images per 
condition per experiment were acquired in a Carl Zeiss LSM700 confocal laser 
scanning microscope using the same acquisition settings. Max projection of z stack 
and merging of channels was done in Fiji. Images were divided in (16 mm)2 patches 
and the patches were randomly grouped. Patches were classified into a 
morphological category and into low, intermediate or high turnover categories, 
manually and blindly for the condition. 
 
7.3. Live	imaging	of	VE-Cadherin-EGFP	expressing	HUVECs	
 
24h after siRNA transfection, knockdown HUVECs were transduced with VE-
cadherin-EGFP adenovirus as described before (Bentley et al., 2014). Briefly, cells 
were incubated with the virus for 24 hours and then washed 3 times to remove viral 
particles. Cells were replated onto 2-well LabTek chambered coverslips (Nunc) 
coated with 10 ug/mL Fibronectin (Sigma, F1141). Imaging was performed 48 hours 
post-transduction. Cells were imaged at 370C under 5% CO2 on LSM 780 (Zeiss) 
using a Plan-Apochromat 63x/1.4 oil objective. Images were acquired at a 260 sec 
time frame.  
 
7.4. Fluorescent	 loss	after	photoconversion	experiments	using	VE-Cadherin-	mEos3.2	
expressing	HUVECs	
 
7.4.1. VE-cadherin	mEos3.2	cloning	
 
mEos3.2 cDNA (Zhang et al., 2012) was cloned downstream of full-length 
human VE-cadherin with a short linker (ARDPPV) and inserted into pAc-GFP-N1 
backbone (Clontech) using NEBbuilder HiFi Assembly mix (NEB). 
 
7.4.2. Fluorescent	loss	after	photoconversion		
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HUVECs double-transfected with YAP/TAZ or scrambled siRNAs and pN1-
CMV-VE-cadherin-mEos3.2 were cultured to confluency in 2-well LabTek chambered 
coverslips (Nunc) coated with 10 ug/mL Fibronectin (Sigma, F1141) in EGM 
(Promocell) supplemented with EGM2 bulletkit (Lonza). Cells were imaged at 370C 
under 5% CO2 on LSM 780 (Zeiss) equipped with Definite Focus stabilizer. Imaging 
was performed using the 488 nm (green mEos3.2 component) and the 561 nm (red 
component) lasers using Plan-Apochromat 63x/1.4 oil objective, 0.26 x 0.26 µm pixel 
size and 5.09 µs pixel dwell time, 16-bit image depth. A circular region of interest 
(ROI) of 21 µm2 area was selected on straight junctions and photoconverted using 
the 405 nm laser. Mean fluorescence intensity in the ROI was monitored in the red 
channel for 15 min with 10s resolution, while the movement of the junction was 
followed in the green channel. Background signal in each frame was estimated by 
measuring mean intensity in non-photoconverted region and subtracted from the 
fluorescence-loss curves. The curves were further corrected for bleaching, using 
parameters estimated from fixed cells. The curves were normalized between the 
mean intensity in the frames before photoconversion and fluorescence intensity 
measured immediately after photoconversion. Normalized curves were smoothed 
using the moving average method; the half-time of redistribution and immobile 
fraction of VE-cadherin were estimated directly from the plots. Only junctions which 
did not substantially move or remodel during the observation time were considered 
for analysis. Analysis was performed using Fiji and Matlab (Mathworks). 
 
 
8. Cell	migration	experiments	
 
8.1. Scratch	wound	assay	
 
24h after siRNA transfection cells were re-plated into a scratch wound assay 
device (IBIDI). On the following day a cell free gap of 500µm was created by 
removing the insert of the device. Images were taken immediately after removing the 
insert (0h) and after 16h. The cell free area was measured in Fiji and used to 
calculate the percentage of wound closure at 16h. 
 
8.2. Cell	coordination	analysis	
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Described before in image analysis. 
 
 
9. Biochemistry		
 
9.1. RNA	extraction	and	quantitative	real	time-polymerase	chain	reaction	
 
RNA was extracted using the RNeasy Mini Kit (Qiagen) according to the 
manufacturer’s instructions. 90ng of RNA were reverse transcribed using RevertAid 
First Strand cDNA Synthesis Kit (ThermoFisher Scientific). qRT-PCR was performed 
using TaqMan reagents and probes (Applied Biosystems) (listed in Supplementary 
File 3). qRT-PCR reactions were run on a StepOnePlus real-time PCR instrument 
(ThermoFisher Scientific) or Quant Studio 6 Flex (Applied Biosystems) and 
expression levels were normalised to human ACTB or human HPRT1 using the 
2deltaCT method. 
 
9.2. Western	blot	
 
Protein was extracted from HUVECs using M-PER protein extraction reagent 
with Halt Protease and Phosphatase inhibitors (Pierce). Proteins concentration was 
assessed using a BCA protein assay kit (Pierce). Proteins were separated by SDS–
PAGE and blotted onto nitrocellulose membranes (Bio-Rad). Membranes were 
probed with specific primary antibodies and then with peroxidase-conjugated 
secondary antibodies. The following antibodies were used: YAP 63.7 (Santa Cruz 
Biotechnology, sc-101199, 1:1000), GAPDH (Millipore, MAB374, 1:4000). The bands 
were visualized by chemiluminescence using an ECL detection kit (GE Heathcare) 
and a My ECL Imager (Thermo Scientific).  
 
10. Dual	luciferase	reporter	assay	
 
Renilla-luciferase reporter assays for TEF-1 (Mahoney et al., 2005), RBPj 
(Jarriault et al., 1995), BRE (Korchynskyi and ten Dijke, 2002, Fritzmann et al., 2009) 
and FOPflash (Korinek et al., 1997)-Luciferase promoter activity were performed as 
follows: 48 hours after gene knockdown by siRNA HUVECs were cotransfected with 
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600 ng of Luciferase reporter gene construct and 300 ng of pRL-TK (Promega) using 
Lipofectamine2000 and incubated for 4 hours. Cell extracts were prepared 72 hours 
post siRNA transfection and 24 hours post Luciferase reporter transfection, and 
luciferase activity was measured using a dual luciferase system as described (Hampf 
and Gossen, 2006). Experiments were carried out in duplicates and results were 
normalized to the correspondent FOPflash/Renilla measurement. 
 
 
11. Notch	and	BMP	inhibition	experiments	
 
A list of the reagents used, together with duration of treatment, can be found 
in Table 2.  
Reagent Reference 
Final 
conc. 
Duration of 
treatment* 
Reference 
DBZ 
14627, Cayman 
chemicals 
0.1uM 20hrs/16hrs (Ridgway et al., 2006) 
Recombinant-
hGremlin 
5190-GR, 
R&D Systems 
0.1ug/
ml 
20hrs 
(Mitola et al., 2010, 
Grillo et al., 2016) 
Recombinant-
hEndoglin 
1097-EN, R&D 
Systems 
0.25u
g/ml 
20hrs 
(Castonguay et al., 
2011) 
LDN-193189 
19396, 
Cayman 
chemicals 
1uM 
20hrs/16hrs/24
h/24h 
(Sanvitale et al., 
2013) 
K02288 
16678, Cayman 
chemicals 
1uM 20hrs 
(Sanvitale et al., 
2013) 
Recombinant 
hAlk1fc 
370-AL-100, R&D 
Systems 
25ng/
ml 
20hrs 
(Mitchell et al., 2010, 
Larrivee et al., 2012) 
  
Table 2: Reagents used for inhibition of Notch and BMP signalling 
* Duration of treatment: Luciferase assay/ Scratch wound assay/ Permeability assay/ VE-
Cadherin staining 
 
 
12. Statistical	Analysis	
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Statistical analyses were performed using GraphPad Prism software and p 
value was determined using unpaired Student t-test between the control and the 
knockout/ knockdown/ condition. Statistical significance was considered for p<0.05. 
Values shown are mean and standard deviation was used as the dispersion 
measure. Biological replicates refer to individual mice for in vivo experiments and 
different wells for in vitro cell culture experiments; independent experiments refer to 
experiments done in different days; technical replicates refer to repeated 
measurements taken from the same sample, both for in vivo and in vitro. Exclusion of 
outliers was done using “Robust regression and Outlier removal” from GraphPad 
Prism software, with a coefficient Q of 1%. A statistical method of sample size 
calculation was not used during study design. For in vivo experiments, we used an 
average of 6 animals per experiment, from different litters, with a minimum of 3 
(detailed number of animals used in figure legends). For in vitro experiments, we did 
a minimum of 3 independent experiments (detailed number of experiments in figure 
legends and source data). When technically possible the investigators were blind to 
the genotype of the animal or cell culture condition during sample processing and 
data analysis.  
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Chapter	 3:	 Sprouting	 vessels	 lacking	 YAP/TAZ	 are	
haemorrhagic	 and	 show	 abnormal	 endothelial	 cell	
organisation	
 
1. Nuclear	 YAP	 and	 TAZ	 are	 found	 in	 sprouting	 endothelial	 cells	 of	 the	
mouse	vasculature	
 
1.1. YAP	and	TAZ	show	distinct	and	complementary	staining	patters	in	the	developing	
mouse	retina	vasculature		
 
To understand if YAP and TAZ are expressed in angiogenic blood vessels, I 
stained retinas from wild-type (WT) mice at P6 for YAP or TAZ protein by 
immunofluorescence. I chose this time point because at P6 the developing blood 
vessels reach approximately 2/3 of the radius of the mouse retina, and one can 
observe both the sprouting front and a more mature plexus, where arteries and veins 
are already specified and vessel pruning is taking place. YAP and TAZ staining 
revealed that these proteins are highly expressed in the developing vasculature of 
the mouse retina, interestingly with distinct and complementary patterns (Figure 3.1): 
while the expression of YAP is lower at the sprouting front than in the remaining 
vasculature, the expression of TAZ is higher at the sprouting front than in the 
remaining vasculature. 
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Figure 3.1. YAP and TAZ are differently expressed in developing blood vessels  
Immunofluorescence staining of YAP (A) and TAZ (B) in WT mouse retinas at P6. Images 
correspond to maximum projection of z-stack. Scale bar: 200µm. 
1.2. YAP	and	TAZ	are	expressed	by	endothelial	cells	and	pericytes	
 
ECs are not the only cell type in blood vessels, but share close contact with 
pericytes and smooth muscle cells. In order to investigate which cells in the retinal 
vessels express YAP and TAZ, I co-stained P6 WT retinas for YAP or TAZ with the 
endothelial membrane and cytoplasm marker Isolectin B4 (IB4), the endothelial 
nuclear marker ERG and the universal nuclear marker DAPI (Figure 3.2). Followed 
by high-resolution single plane confocal imaging, this allowed me to distinguish 
between endothelial signal (cells with ERG positive nuclei) and signal from mural 
cells (cells with ERG negative nuclei). Furthermore, pericytes could be distinguished 
as having ERG negative nuclei, but being also enveloped by a weakly IB4 positive 
membrane. By doing so, I observed that both ECs (Figure 3.2 white arrowheads) 
and pericytes (Figure 3.2 yellow arrowheads) expressed YAP and TAZ in the 
developing vasculature of the mouse retina. 
 
 
Figure 3.2. In blood vessels, YAP and TAZ are expressed in endothelial and perivascular 
cells 
Immunofluorescence staining of IB4 (B,G, blue), ERG (C, H, red), YAP (D) or TAZ (I) (green) 
and DAPI (E, J, white) in WT mouse retinas at P6. Both ECs and pericytes are within IB4 staining, but 
only ECs are positive for the nuclear marker ERG. White arrowhead, endothelial nuclei. Yellow 
arrowhead, nuclei of pericyte. Images correspond to a single confocal plane. Scale bar: 10µm. 
 
1.3. Nuclear	YAP	and	TAZ	is	found	in	sprouting	endothelial	cells	
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As the activity of YAP and TAZ depend strongly on their relative presence in 
the nucleus or cytoplasm, I specifically looked for the subcellular localisation of YAP 
and TAZ in the developing vasculature of the mouse retina. For this, I further 
analysed the retinas co-stained for YAP or TAZ, for ERG – marking endothelial 
nuclei –, and labelled with IB4 – marking endothelial cytoplasm. Specifically in ECs 
(Figure 3.3), I observed that while the expression of YAP was comparable in all 
areas of the vasculature, the expression of TAZ was much higher in ECs at the 
sprouting front than in those in more mature vessels (remodelling plexus, arteries 
and veins), where little staining signal was observed. For both YAP and TAZ there 
was no variability of subcellular location in ECs in the mature plexus; there, YAP is 
exclusively cytoplasmic and TAZ is similarly nuclear and cytoplasmic. In contrast, the 
subcellular location of YAP and TAZ is variable in ECs at the sprouting front: for 
YAP, ECs show different amounts of nuclear protein, although in all cases less 
nuclear than cytoplasmic signal is seen; for TAZ, some ECs show preferential 
nuclear signal, others show similar signal between nucleus and cytoplasm and others 
show preferential cytoplasmic signal. This variable subcellular location of YAP/TAZ in 
sprouting ECs is present both in tip and stalk cells, suggesting that they are not 
primarily regulated by tip/stalk cell identities.  
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Figure 3.3. YAP and TAZ are nuclear in some sprouting endothelial cells 
Immunofluorescence staining of YAP (green, A-D and A’-D’) and TAZ (green, E-H and E’-H’) in 
P6 WT mouse retinas. Retinas were co-stained with the endothelial membrane and cytoplasm marker 
Isolectin-B4 (IB4; blue) and with antibodies against the endothelial nuclei marker ERG (red). White 
dotted lines, outline of endothelial nuclei. Yellow dotted lines, outline of perivascular cells’ nuclei. Green 
arrowheads, nuclear localisation of YAP and TAZ. Red arrowheads, cytoplasmic localisation of YAP and 
TAZ. Yellow arrowheads, junctional localisation of YAP and TAZ. Images correspond to single confocal 
planes. n>3 animals for each staining. Scale bar: 10µm. 
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1.4. YAP	and	TAZ	also	 localise	to	endothelial	adherens	 junctions	 in	the	mouse	retina	
vasculature	
 
My analysis further revealed a linear pattern of staining for YAP and TAZ not 
suggestive of nuclear or cytoplasmic location. The signal instead overlapped with 
that from VE-Cadherin staining, showing that YAP and TAZ also localise to adherens 
junctions in ECs (Figure 3.4). Interestingly, I found this junctional location to be 
mostly present in veins and in the remodelling plexus, and absent at the sprouting 
front and arteries. Furthermore, the presence of YAP at adherens junctions was 
stronger and broader than that for TAZ. 
 
 
Figure 3.4. YAP and TAZ localise at endothelial adherens junctions in the mouse retina 
Immunofluorescence stainings of YAP (green, A-C,A’-C’), TAZ (green, D-F, D’-F’) and VE-
Cadherin (red, B,E,B’,E’) were performed in WT mouse retinas at P6. Arrows, co-localisation of YAP or 
TAZ with VE-Cadherin. Images correspond to single confocal planes. n> 3 pups per staining. Scale bar 
A-C and D-F 10µm, A’-C’ and D’-F’ 3µm. 
 
Together, these results suggest that: 
1) YAP and TAZ do not have fully overlapping functions,  
2) they are differently regulated in mature vs. sprouting ECs and  
3) they may act as transcriptional co-activators in sprouting ECs. 
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2. Endothelial	YAP	and	TAZ	are	required	for	vessel	growth	and	density	and	
for	the	formation	of	a	homogeneous	plexus	
 
2.1. Endothelial	 YAP	 and	 TAZ	 are	 efficiently	 lost	 by	 tamoxifen	 injection	 using	 the	
PdgfbCreERT2	line	
 
To understand the cell autonomous role of endothelial YAP and TAZ, I took 
advantage of the Cre-Lox technology to specifically delete YAP and TAZ from ECs 
during post-natal sprouting angiogenesis. In order to do so, I crossed mice carrying 
Yap and/or Taz floxed genes with mice expressing PdgfbCreERT2. In this line, the 
expression of the Cre recombinase is under the control of the endothelial specific 
promoter Pdgfb, restricting its expression to ECs. Furthermore, the CRE is fused to a 
mutated estrogen receptor, causing its sequestration in the cytoplasm until exposure 
to tamoxifen. By crossing females homozygous for the floxed gene(s) with males 
homozygous for the floxed gene(s) and heterozygous for the Cre, I obtained in the 
same litter both mutant (Cre positive) and control pups (Cre negative). To assess the 
efficiency of protein deletion, I injected pups with tamoxifen at P1 and P3 and 
performed immunostaining for YAP or TAZ in the mouse retina at P6. This protocol 
efficiently led to the deletion of endothelial YAP or TAZ (Figure 3.5).  
 
 
Figure 3.5. YAP and TAZ proteins are efficiently lost upon Cre-mediated genetic deletion 
Yap iEC-KO (Yapfl/fl Pdgfb-iCreERT2+/wt), Taz iEC-KO (Tazfl/fl Pdgfb-iCreERT2+/wt) and 
respective littermate control mice were injected with tamoxifen at P1 and P3. At P6, retinas were stained 
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for YAP (green, A, A’, B, B’), TAZ (green, C, C’, D, D’), and with Isolectin B4 (IB4; blue, A,B,C,D). Scale 
bar: 20µm. 
 
From here on, I will refer to Yapfl/fl PdgfbCreERT2 +/wt mice as Yap iEC-KO, 
Yapfl/fl mice as Yap Control, Tazfl/fl PdgfbCreERT2 +/wt mice as Taz iEC-KO, Tazfl/fl 
mice as Taz Control, Yapfl/flTazfl/fl PdgfbCreERT2 +/wt mice as YapTaz iEC-KO and 
Yapfl/flTazfl/fl mice as YapTaz Control. 
 
2.2. YAP/TAZ	are	 required	 for	vessel	extension	and	density	 in	 the	developing	mouse	
retina	
 
To investigate the role of YAP and TAZ during vessel development, I 
collected retinas from Yap iEC-KO and Taz iEC-KO pups at P6 and stained the blood 
vessels using IB4. The single deletion of endothelial YAP or TAZ led to mild vascular 
defects (Figure 3.6). Yap iEC-KO retinas show an 8% reduction in the radial 
expansion of the vasculature (92+/-5% of the control, p=0.0123) and a 9% reduction 
in the vascular density of the plexus (91+/-4% of the control, p=0.0002). Taz iEC-KO 
retinas do not show a defect on the radial expansion of the vasculature but display a 
7% reduction in the vascular density of the plexus (93+/-6% of the control, 
p=0.0214). Both Yap iEC-KO and Taz iEC-KO retinas show no defect in the 
branching frequency of the plexus. Unlike the single mutants, the deletion of both 
proteins in double mutant mice (YapTaz iEC-KO) causes a dramatic vascular 
phenotype. YapTaz iEC-KO retinas show a 21% reduction in the radial expansion of 
the vasculature (79+/-14% of the control, p=0.0012), a 26% reduction in the vascular 
density of the plexus (74+/-7% of the control, p<0.0001) and a 55% decrease in the 
branching frequency of the vessels (45+/- 15% of the control, p<0.0001). These 
results show that YAP/TAZ are required for vessel development, and suggest that 
they can functionally compensate for the loss of the other. 
Results 
58 
 
Figure 3.6. Endothelial YAP and TAZ are required for vessel growth and branching  
A-F, Retinas from P6 Yap iEC-KO (B), Taz iEC-KO (D) and YapTaz iEC-KO (F), and 
respective control pups (A, C, E) were stained with Isolectin B4 (IB4). Scale bar: 200µm.  
G-I, Radial expansion (G), vessel density (H) and branching frequency (I) in Yap iEC-KO, Taz 
iEC-KO and YapTaz iEC-KO. Results are shown as percentage of the respective controls. Box and 
whiskers plot: whiskers show minimum to maximum value; box extends from the 25th to 75th 
percentiles; line shows median; + sign shows mean. n≥ 5 pups. p values were calculated using unpaired 
t-test. *, p<0.05; **, p<0.01; ****, p<0.0001. 
 
To look for evidence of compensation between YAP and TAZ at the protein 
level, I stained Yap iEC-KO retinas for TAZ and Taz iEC-KO retinas for YAP. Yap 
iEC-KO retinas show a clear increase in nuclear TAZ (Figure 3.7). This is true not 
only at the sprouting front, where normally some ECs have nuclear YAP, but 
interestingly also for the remaining vasculature, where normally all ECs express 
cytoplasmic YAP. In other words, the loss of YAP, regardless of its presence in the 
Results 
59 
nucleus or cytoplasm, leads in ECs to an increase in TAZ nuclear protein. In 
contrast, Taz iEC-KO retinas did not show increased nuclear YAP in any region of 
the vasculature, and also did not show a clear difference in YAP staining intensity 
(not quantified). These results show that TAZ compensates for the loss of YAP with 
increased nuclear shuttling.  
 
 
Figure 3.7. TAZ compensates for the loss of YAP in endothelial cells in vivo 
Retinas from P6 Yap iEC-KO (B, D and B’, D’) and littermate controls (A, C and A’, C’) were 
stained by immunofluorescence for TAZ. Green arrowheads, nuclear Taz staining. A, B, A’, B’ images 
correspond to maximum projection of z stack. C, D, C‘, D’ correspond to single confocal planes. Scale 
bar: A-D 50µm, A’-D’ 20µm. 
 
2.3. YAP	and	TAZ	are	required	for	the	homogeneity	of	the	vascular	plexus		
 
On closer observation, I noticed that the organisation of the capillary bed was 
affected on YapTaz iEC-KO mice (Figure 3.8 A-F). In control mice, the loops 
between blood vessels are of similar size and shape, reflecting the homogeneous 
distribution of ECs throughout space. Yap iEC-KO and Taz iEC-KO mice showed 
bigger vascular loops than control mice, but no difference in the variability of size and 
shape of these loops (Figure 3.8 B, D, G-I). In contrast, in Yap/Taz iEC-KO mice the 
loops were not only bigger but also more variable in size, and shape (Figure 3.8 F, 
G-I) than in control mice. These results indicate that endothelial YAP and TAZ are 
critical for the development of a homogeneous blood vessel network. 
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Figure 3.8. Endothelial YAP and TAZ are required for the homogeneity of the plexus 
A-F, Retinal vascular plexus of P6 Yap iEC-KO (B), Taz iEC-KO (D) and YapTaz iEC-KO (F), 
and respective control pups (A, C, E) stained with Isolectin B4 (IB4). Scale bar: 50µm. 
G, Area of vessel loops in the retinal vascular plexus of Yap iEC-KO, Taz iEC-KO and YapTaz 
iEC-KO. H-I, Standard deviation of the area (H) and circularity (I) of the vessels loops in Yap iEC-KO, 
Taz iEC-KO and YapTaz iEC-KO vascular plexus. G, H, I, Results shown as percentage of the 
respective controls. Box and whiskers plot: whiskers show minimum to maximum value; box extends 
from the 25th to 75th percentiles; line shows median; + sign shows mean. n≥ 5 pups. p values were 
calculated using unpaired t-test. *, p<0.05; **, p<0.01; ****, p<0.0001. 
 
2.4. TAZ	and	YAP/TAZ	mutants	show	crosses	between	arteries	and	veins	
 
In addition to affecting the capillary network, the endothelial deletion of YAP 
and TAZ also impacted the organisation of arteries and veins (Figure 3.9). In control 
retinas arteries and veins run parallel to each other, separated by the capillary 
network, and do not normally cross (Figure 3.9 A, A’). In contrast, Yap/Taz iEC-KO 
retinas often show arteriovenous crosses (Figure 3.9 B, B’ yellow arrowheads and 
D). Furthermore, some of these crosses occur in association with venous defects. 
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Normally in the mouse retina vasculature, arteries branch into smaller arteries in 
oblique angles, while veins run straight and receive blood from capillaries connecting 
in perpendicular angles (Figure 3.9A). Yap/Taz iEC-KO retinas however show veins 
that branch or split (Figure 3.9 B, B’, C, C’ yellow circles and E). In more severe 
cases, it is difficult to distinguish between arteries and veins in Yap/Taz iEC-KO 
retinas, as veins show multiple oblique connections with surrounding vessels (Figure 
3.9 C, C’ yellow circles). Yap iEC-KO retinas show no increase in arteriovenous 
crosses (Chapter 3 – Figure 9D) and vein defects (Figure 3.9 E), but interestingly, 
both were already present in Taz iEC-KO retinas (Figure 3.9 D and E). 
 
 
Figure 3.9. YAP and TAZ regulate the organisation of arteries and veins 
A-C, Retinas from two P6 YapTaz iEC-KO mice (B,C), and one control mouse (A) stained with 
Isolectin B4 (IB4). A’-C’, mask of arteries and veins from A-C respectively. Red, arteries; Blue, veins. 
Yellow arrowheads, arterio-venous crossover. Yellow circle, vein defect (splitting of branching). Scale 
bar: 500µm.  
D, E, Number of AV crosses (E) and vein defects (E) per animal in Yap iEC-KO, Taz iEC-KO, 
YapTaz iEC-KO and respective controls. Scatter dot plot: each dot represents one animal. Data are 
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mean +/- SD. p values were calculated using unpaired t-test. *, p<0.05; **, p<0.01; ****, p<0.0001. n= 6 
pups per condition except for quantification of vein defects in YapTaz iEC-KO (n=4). 
 
3. At	 the	 sprouting	 front,	 YAP/TAZ	maintain	 the	 integrity	 of	 the	 vascular	
barrier	and	promote	the	distribution	of	endothelial	cells		
 
3.1. YAP/TAZ	are	required	for	sprouting	
 
To understand if the defects described above were related to a defect in 
sprouting of new vessels, I analysed with more detail the sprouting front of Yap and 
Taz single mutants and Yap/Taz double mutants (Figure 3.10 A-F). Yap iEC-KO 
retinas do not show a change in the number of sprouts per length of the sprouting 
front (106+/-8% of the control, p=0.3085) (Figure 3.10 A, B, G). In contrast, Taz iEC-
KO retinas have an 18% reduction in the number of sprouts (82+/-5% of the control, 
p=0.0127) (Figure 3.10 C, D, G). As with previous parameters, the deletion of both 
proteins also increases the sprouting defect, so that YapTaz iEC-KO retinas show a 
30% reduction in the number of sprouts (30+/-10% of the control, p=0.0004) (Figure 
3.10 E, F, G). These results show that YAP/TAZ are required for sprouting of new 
blood vessels, and also suggest that TAZ has a more preponderant role in sprouting 
than YAP. 
 
 
Figure 3.10. Endothelial YAP and TAZ are required for vascular sprouting 
A-F, Retinas from P6 Yap iEC-KO (B), Taz iEC-KO (D) and YapTaz iEC-KO (F), and 
respective control pups (A, C, E) were stained with Isolectin B4 (IB4). Images show the sprouting front. 
Scale bar: 100µm. 
G, Number of sprouts per surface extension in Yap iEC-KO, Taz iEC-KO and YapTaz iEC-KO. 
Results are shown as percentage of the respective littermate controls. Box and whiskers plot: whiskers 
show minimum to maximum value; box extends from the 25th to 75th percentiles; line shows median; + 
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sign shows mean. p values were calculated using unpaired t-test between the mutant and respective 
littermate control. *, p<0.05; **, p<0.01; ****, p<0.0001. n= 5 pups per condition. 
 
3.2. YAP/TAZ	 are	 required	 for	 endothelial	 cells	 to	 distribute	 and	 rearrange	 in	
sprouting	vessels	
 
 Not only have YapTaz iEC-KO retinas less sprouts than control 
retinas, they also present severe morphological defects. To further analyse the 
shape defects and organisation of ECs in sprouting vessels, I co-stained retinas for 
IB4 and ERG and imaged retinas in higher resolution. Sprouts of control mice 
(Figure 3.11, A, A’) are elongated and show long cellular protrusions towards the 
non-vascularised front. In contrast, sprouts from YapTaz iEC-KO mice are rounder in 
shape and lack cellular protrusions (Figure 3.11, B, B’). Moreover, endothelial nuclei 
in sprouts of control mice are elongated and homogeneously distributed throughout 
the vessels (Figure 3.11 A’). In YapTaz iEC-KO mice however, endothelial nuclei 
are rounder and show irregular spacing, often appearing aggregated within the 
sprouts (Figure 3.11 B’). Together, these morphological defects suggest that ECs 
lacking YAP/TAZ are less able to migrate and rearrange in sprouting vessels.  
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Figure 3.11. Combined loss of YAP and TAZ leads to sprouting shape defects and nuclei 
clumping 
A, B, P6 retinal vessels labelled with Isolectin B4 (IB4, green) and stained for ERG (magenta, 
marking endothelial nuclei) in YapTaz iEC-KO (B) and littermate control mice (A). A’, B’, magnification of 
boxed areas in A and B. Scale bar: A, B 100µm, A’, B’ 25µm. 
 
In order to assess the arrangement of cells within vessels, I co-stained retinas 
for IB4 and VE-Cadherin, the main component of vascular adherens junctions. In 
control retinas, ECs organise into multicellular vessel tubes, highlighted by the 
presence of two or more VE-Cadherin junctions running along the axis of the vessel 
(Figure 3.12 A). A few unicellular vessel segments can also be observed in control 
retinas but only in regressing vessels, which can be identified by their decreasing 
calibre (Figure 3.12 A red arrowhead). In contrast, in YapTaz iEC-KO retinas I 
found many unicellular vessel segments that did not localise to regressing vessels, 
but instead existed in vessels of normal calibre (Figure 3.12 B). Moreover, the 
appearance of adherens junctions was also affected by the loss of endothelial 
YAP/TAZ. In control vessels, the junctions between ECs are thin and linear (Figure 
3.12 A”). In contrast, in YapTaz iEC-KO vessels I often observed tortuous junctions 
between ECs (Figure 3.12 B”), again pointing towards a defect in cell elongation 
and rearrangements. 
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Figure 3.12. The combined loss of YAP and TAZ leads to adherens junctions’ defects in 
vivo 
A, B, P6 retinal vessels labelled with Isolectin B4 (IB4, green) and stained for VE-Cadherin 
(magenta) in YapTaz iEC-KO (B) and control mice (A). Red arrowheads, no longitudinal VE-Cadherin 
labelled junction along vessel axis denoting unicellular vessel segments. A’, B’, A’’, B’’, magnification of 
boxed areas in A and B. A’2, B’2, individual ECs are highlighted in different colours. Scale bar: A,B 
25µm, A’,B’ 10µm, A”,B” 5µm. n=4 control/4 KO pups. 
 
Moreover, I found in YapTaz iEC-KO retinas aberrant vessel crosses not only 
in arteries and veins as I have here already reported but also in the capillaries near 
the sprouting front. In the control retina at P6, blood vessels grow in one single layer 
(Figure 3.13 A). However, in YapTaz iEC-KO retinas I found several vessel crosses 
in three dimensions (Figure 3.13 B). These suggest that vessels failed to 
anastomose or stabilise connections following sprouting, and instead passed each 
other. 
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Figure 3.13. The combined loss of YAP and TAZ leads to vessel crosses in vivo 
A, B, P6 retinal vessels labelled with Isolectin B4 (IB4) in YapTaz iEC-KO (B) and control mice 
(A). Red arrowheads, vessel crosses. A’, B’, magnification of boxed areas in A, B. A’’,B’’, depiction of 
vessels in A’ and B‘, where different colours represent vessels in different 3D planes. Scale bar: A,B 
100µm, A’-B’ 20µm. n=4 control/4 KO pups. 
 
3.3. YapTaz	iEC-KO	retinas	present	haemorrhages	at	the	sprouting	front		
 
While dissecting retinas from YapTaz double mutant litters I observed that 
some had haemorrhages, which I had not seen while processing retinas from Yap or 
Taz single mutant litters. Staining for TER119, a marker of red blood cells, confirmed 
the presence of large haemorrhages in YapTaz iEC-KO retinas (Figure 3.14), and 
also their absence in the single mutants (data not shown). Interestingly, the 
haemorrhages in YapTaz iEC-KO retinas were predominantly located at the 
sprouting front, and rarely present in the mature plexus. YapTaz iEC-KO P6 brains 
showed no signs of haemorrhages on visual inspection (data not shown), and mice 
survived normally up to P28, thus excluding life-threatening haemorrhages during 
that period of time. These results suggest that especially actively sprouting ECs 
require YAP/TAZ in order to maintain the vascular barrier function. 
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Figure 3.14. Endothelial YAP and TAZ prevent haemorrhages at the sprouting front  
A, B, P6 retinal vessels labelled with Isolectin B4 (IB4, green) and stained for TER119 
(magenta, marking red blood cells) in YapTaz iEC-KO (B) and control mice (A). Red arrowheads, 
haemorrhages. A’, B’, magnification of boxed areas in A and B. Scale bar: A,B 1000µm, A’, B’ 100µm. 
n> 4 pups. 
 
3.4. Pericytes	 covering	 YapTaz	 iEC-KO	 vessels	 at	 the	 sprouting	 front	 show	 abnormal	
expression	of	αSMA	
 
Deficient coverage of vessels by mural cells – pericytes and smooth muscle 
cells - has been associated not only with loss of barrier function (Armulik et al., 2010) 
but also with haemorrhages (Li et al., 2011). Furthermore, vessel coverage by mural 
cells has been inversely correlated with vessel diameter and vessel density (Enge et 
al., 2002, Bjarnegard et al., 2004, Lindahl et al., 1997, Hellstrom et al., 2001, Armulik 
et al., 2010), both of which are affected in YapTaz iEC-KO vessels. As such, I sought 
to address whether endothelial YAP/TAZ affects the coverage of vessels by mural 
cells. To do so, I co-stained YapTaz iEC-KO retinas for IB4, with the pericyte marker 
NG2 and with the vascular smooth muscle cell marker αSMA, and focused my 
analysis at the sprouting front, as the place of preferential haemorrhages (Figure 
3.15). There, the extension of coverage of YapTaz iEC-KO vessels by NG2 positive 
cells is not different from control vessels (Figure 3.15 B, D, G, I). However, αSMA 
signal is present in YapTaz iEC-KO retinas at the sprouting front (Figure 3.15 H, J), 
where it is practically absent in control retinas (Figure 3.15 C, E). On closer 
observation (Figure 3.15 K), I could identify that the αSMA signal followed the same 
shape as the NG2 signal, with both protruding slightly outside of the IB4 marked 
endothelial tube. These results show that some of the pericytes in the sprouting front 
of YapTaz iEC-KO retinas abnormally express αSMA. By looking at the distribution of 
αSMA signal throughout the entire retina (Figure 3.15 L-P), I observed that its 
expression is not different in the mature plexus of YapTaz iEC-KO and controls. 
There, αSMA signal is restricted to arteries, labelling the smooth muscle cells there 
present. However, at the sprouting front the αSMA signal is distinctly different 
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between YapTaz iEC-KO and controls. In control retinas the αSMA signal is sharply 
lost when arteries branch into progressively smaller vessels, approximately at 2/3 of 
the distance between the optic nerve and the sprouting front; there is almost no 
αSMA signal in the distal 1/3 of the retinal vasculature. In contrast, in YapTaz iEC-
KO retinas the αSMA signal does not stop but instead decreases when arteries 
divide into smaller branches, continuing until the capillaries at the sprouting front 
(Figure 3.15 N, O, P). Sprouting front capillaries upstream of a vein show less or no 
αSMA signal. The difference in αSMA expression by pericytes in capillaries close to 
an artery or to a vein suggests that local mechanisms other than the endothelial loss 
of YAP/TAZ could account for the phenotype. This could reflect an indirect response 
to altered hemodynamics in the YapTaz iEC-KO retina vasculature, or to an 
increased inflammatory response caused by haemorrhages. Computer simulations 
showed that the sprouting front vessels of the P6 WT mouse retina experience very 
low levels of shear stress (Bernabeu et al., 2014). Because of the severe reduction in 
vessel density and branches in YapTaz iEC-KO retinas, an increase in shear stress 
is expectable, as there is less total capacity to disperse the blood volume coming 
from the arteries feeding the retina. Another plausible mechanism is inflammation. 
Although quiescent pericytes do not express αSMA, its expression can be 
upregulated in inflammation (Armulik et al., 2011). Importantly, more macrophages 
are found surrounding YapTaz iEC-KO vessels than control vessels (data not 
shown), which is a common finding when haemorrhages are present, and denotes 
increased inflammation.  
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Figure 3.15. Pericytes in the sprouting front of YapTaz iEC-KO retinas ectopically 
express αSMA 
A-J, Retinas from P6 YapTaz iEC-KO (F-J), and control pups (A-E) stained with Isolectin B4 
(IB4), NG2 and αSMA. Scale bar: 50 µm. K, Magnification of boxed area in F-J. Scale bar: 10 µm.  
L-O, Retinas from P6 YapTaz iEC-KO (N, O), and control pups (L, M) stained with Isolectin B4 
(IB4) and αSMA. Blue dashed line, sprouting front of vasculature. Scale bar: 500 µm. P, Q, 
Magnification of boxes areas in N, O. P, sprouting front capillaries downstream of artery. R, sprouting 
front capillaries upstream of vein. Scale bar: 100 µm. 
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4. Summary	and	conclusions	
 
In this chapter I have shown that YAP and TAZ are highly expressed by ECs 
of the developing vasculature, and localise to the nucleus at the sprouting front. This 
is especially true for TAZ; differently, YAP mostly localises to the cytoplasm of ECs. 
My functional experiments using single and double mutant mice have shown 
that although YAP and TAZ have a great deal of redundancy (mostly evident from 
the mild phenotype of the single mutants and the striking phenotype of the double 
mutant), they do not show fully overlapping functions. For instance, only TAZ 
mutants show hyposprouting, AV crosses and vein defects. This signifies that 
although redundancy is present, some functions are still unique for YAP and TAZ. 
I have shown that YapTaz iEC-KO retinas have decreased radial expansion, 
vascular density, sprouting and branching. These phenotypes could be related to a 
defect in getting sufficient numbers of ECs to populate the retina. It is in fact one of 
the best-documented functions of YAP and TAZ, that of regulating proliferation and 
apoptosis. However, other described phenotypes – defective integrity of vessel 
barrier, defective cell distribution and elongation, vessel crosses – point towards a 
possible role of YAP and TAZ in regulating junctional morphology and cell migration.  
In the next chapter I will describe my findings relating to how YAP and TAZ 
control the referred cellular processes in ECs, and possible molecular mechanisms. 
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Chapter	 4:	 YAP	 and	 TAZ	 increase	 JAIL	 formation	 and	
junctional	turnover	
 
1. YAP	 and	 TAZ	 increase	 endothelial	 cell	 proliferation	 downstream	 of	
mechanical	stimuli	
 
1.1. Endothelial	YAP	and	TAZ	regulate	cell	numbers	 in	 the	mouse	retina	 through	the	
promotion	of	cell	proliferation	
 
The growth of new vessel sprouts requires endothelial proliferation. This can 
be readily appreciated in the developing mouse retina vasculature, where ECs at the 
sprouting front are highly proliferative, in contrast with the ones in more mature 
vessels (Figure 4.1).  
 
 
Figure 4.1. Endothelial cells at the sprouting front are highly proliferative 
A-C, Retinas from P6 mice stained with Isolectin B4 (IB4) (A, B, black) and EdU marking nuclei 
of S-phase cells (A, C, red). Mice were injected with EdU 2 hrs prior to culling to analyse endothelial 
proliferation. A well-delimited proliferation area is seen at the sprouting front. Scale bar: 200µm.  
 
When the ability of ECs to proliferate is compromised (Ubezio et al., 2016), 
retinal vessels show decreased radial expansion, decreased vascular density, 
decreased protruding tip cells and decreased branching points. As all these 
parameters were affected in YapTaz iEC-KO retinas, and nuclear YAP and TAZ are 
found in the same area where proliferation takes place, I investigated whether YAP 
and TAZ impacted cell proliferation. Moreover, and as referred to before, YAP and 
TAZ are critical regulators of cell proliferation in many cell types. To do so, I pulsed 
mutant mice with EdU, a nucleoside analog of thymidine that is incorporated into 
DNA during active DNA synthesis, 2 hrs before culling. I then co-stained retinas for 
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endothelial nuclei (ERG) and blood vessels (IB4) to make sure I evaluated 
endothelial proliferation and not proliferation from other cells in the retina (Figure 4.2 
A, B). EC proliferation was 24% decreased in Yap iEC-KO retinas (76 +/- 10 % of the 
control, p=0.0469), but not affected in Taz iEC-KO (Figure 4.2 C). Consistent with 
previous observations the decrease in cell proliferation was strongest in Yap/Taz 
iEC-KO retinas, showing a 33% reduction in proliferation (67 +/- 26% of the control, 
p=0.0059) (Figure 4.2 A, B, C).  
 
 
Figure 4.2. YAP/TAZ promote endothelial proliferation in the mouse retina 
A, B, P6 retinal vessels labelled with Isolectin B4 (IB4, grey) and stained for EdU (red, marking 
S phase positive cells) and ERG (green, marking endothelial nuclei) in YapTaz iEC-KO (B) and 
littermate control mice (A). A’, B’, mask of Erg + and EdU + cells indicating proliferating ECs. Scale bar: 
50µm. 
C, Quantification of endothelial proliferation in Yap iEC-KO (n=3 control/4 KO pups), Taz iEC-
KO (n=5 control/5 KO pups) and YapTaz iEC-KO (n=8 control/7 KO pups). Number of EdU-positive and 
ERG-positive cells per IB4 labelled vascular area was calculated for each genotype. Results are shown 
as percentage of the respective littermate controls. Box and whiskers plot: whiskers show minimum to 
maximum value; box extends from the 25th to 75th percentiles; line shows median; + sign shows mean. 
p values were calculated using unpaired t-test between the mutant and respective littermate control. *, 
p<0.05; **, p<0.01. 
 
I also investigated if an additional cause for decreased vascularization in 
YapTaz iEC-KO retinas would be increased endothelial apoptosis. Yorkie, the YAP 
ortholog in the fly, is not only pro-proliferative but also anti-apoptotic (Huang et al., 
2005). YAP however has been shown to be both anti (Rosenbluh et al., 2012) (Marti 
et al., 2015, Schwartzman et al., 2016) and pro (Tomlinson et al., 2010, Cottini et al., 
2014) apoptotic depending on the cell type and context. To evaluate if YAP and TAZ 
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affect endothelial apoptosis in the retina vasculature I stained mutant retinas for the 
active form of the executioner caspase 3 (cleaved caspase 3) together with IB4 and 
measured the number of apoptosis events (Figure 4.3). By doing so, I did not 
observe an increase in apoptosis for any of the mouse mutants (Figure 4.3 C). 
Instead, there was a tendency for decreased apoptosis in all mutants, however not 
statistically significant. This clearly shows that YAP/TAZ do not inhibit endothelial 
apoptosis. 
 
 
Figure 4.3. YAP/TAZ do not inhibit endothelial apoptosis in the mouse retina 
A, B, P6 retinal vessels labelled with Isolectin B4 (IB4, grey) and stained for cleaved caspase 3 
(red) in YapTaz iEC-KO (H) and littermate control mice. A’, B’, magnification of boxed area in A, B. Red 
arrowheads, cleaved caspase 3 positive endothelial cell. Black arrowheads, cleaved caspase 3 outside 
vessels. Scale bar: A,B 100µm, A’-B’ 50µm. 
C, Quantification of endothelial apoptosis in Yap iEC-KO (n=7 control/7 KO pups), Taz iEC-KO 
(n= 4 control/4KO pups) and YapTaz iEC-KO (n=5 control/4 KO pups). Results are shown as 
percentage of the respective littermate controls. Box and whiskers plot: whiskers show minimum to 
maximum value; box extends from the 25th to 75th percentiles; line shows median; + sign shows mean. 
p values were calculated using unpaired t-test between the mutant and respective littermate control. ns, 
p>0.05.  
 
Together, my results suggest that a decrease in endothelial proliferation, but 
not an increase in apoptosis, can lead to the vascularisation defects in Yap/Taz iEC-
KO retinas. 
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1.2. YAP	 is	 required	 for	 stretch	 induced	 proliferation,	 but	 not	 for	 VEGF	 induced	
proliferation	
 
Endothelial proliferation is triggered by a variety of stimuli, some of which are 
chemical in nature, while others are mechanical (Akimoto et al., 2000, Lacolley, 
2004). As YAP and TAZ are regulated both by chemical and mechanical stimuli in 
other cell types, I aimed to investigate which stimuli would be upstream of YAP/TAZ 
dependent endothelial proliferation.  
 
To do these experiments I turned to in vitro culture of HUVECs and 
established a loss of function system by doing gene knockdown for YAP and/or TAZ 
using siRNAs in HUVECs. This strategy efficiently led to the loss of YAP and/or TAZ 
protein, as I could verify by immunofluorescence (Figure 4.4 A-H) and western-blot 
(Figure 4.4 I). 
 
 
Figure 4.4. Efficient loss of YAP and TAZ protein after gene knockdown by siRNA 
HUVECs treated with non-targeting siRNA (siCTR) or siRNA targeting YAP, TAZ and YAP 
+TAZ for 24h.  
A-H, Immunofluorescence staining for YAP (green, A-D) or TAZ (green, E-H) and labelling of 
nuclei with DAPI (magenta) 72h after siRNA transfection. Scale bar: 10µm.  
I, Western blot for YAP/TAZ and GAPDH 72h after siRNA transfection 
 
The first stimuli I evaluated was VEGF, a critical endothelial mitogen (Hoeben 
et al., 2004). To understand if YAP and/or TAZ responded to VEGF with increasing 
proliferation, I treated confluent monolayers of HUVECs knocked down for YAP 
and/or TAZ with increasing dosages of VEGF and evaluated the cell cycle using flow 
cytometry. By plotting the fold change in % of S phase cells after VEGF stimulation, I 
could observe that the knockdown of YAP, TAZ and YAP/TAZ together did not 
abrogate the increase in proliferation with VEGF (Figure 4.5 A). Moreover, treating 
cells with VEGF did not lead to a shift in the intracellular location of YAP and TAZ, 
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suggesting that VEGF is not upstream of YAP and TAZ (Figure 4.5 B-K). These 
results show that YAP and TAZ are not required for VEGF induced proliferation.  
 
 
Figure 4.5. YAP and TAZ are not required for VEGF induced proliferation 
A, Endothelial proliferation with increasing concentrations of VEGF treatment in YAP, TAZ and 
YAP/TAZ knockdown cells and control. HUVECs were treated with 0, 40, 200 or 1000 ng/mL VEGF for 
24h and the percentage of cells in S phase was determined by flow cytometry. Graph shows the mean 
+/- SD of the fold change in percentage of S phase positive cells relative to 0 ng/mL of VEGF treatment. 
n= 3 independent experiments; > 50.000 cells analysed per experiment per condition. 
B-I, Confluent HUVECs were treated with 40ng/mL of VEGF for 30 min (C,G), 1h (D,H) and 3h 
(E,I) or with no VEGF (B,F) and stained for YAP (B-E) or TAZ (F-I) and DAPI (not shown).Scale bar: 
25µm. 
J, K, Quantification of nuclear to cytoplasmic ratio of YAP (J) or TAZ (K) with VEGF treatment 
of one representative experiment. Nuclear/cytoplasmic ratio > 1, YAP/TAZ nuclear; nuclear/cytoplasmic 
ratio < 1, YAP/TAZ cytoplasmic. At least 200 cells quantified per condition per experiment. n= 2 
independent experiments. 
 
I then asked whether YAP and TAZ mediated endothelial proliferation in 
response to mechanical stretch. To do so, I subjected HUVECs to cycles of 
mechanical stretch for 24hrs and compared their proliferative response to cells that 
were not stretched, in control conditions and upon YAP, TAZ and YAP/TAZ 
knockdown (Figure 4.6). Proliferation was after assessed by EdU incorporation. 
Upon stretch, control cells showed a 5-fold average increase in proliferation (5+/-
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2.6%), and this effect was reduced upon knockdown of VE-Cadherin, confirming 
previous observations (Liu et al., 2007). The knockdown of YAP, but not of TAZ, led 
to a significant decrease in stretch-induced proliferation (2+/-0.6%, p=0.0351). The 
knockdown of YAP/TAZ showed a tendency to decreased proliferation in response to 
stretch but did not reach statistical significance. Thus YAP is required for EC 
proliferation in response to mechanical stimulation at cell-cell junctions. 
 
 
Figure 4.6. YAP is required for stretch induced proliferation 
Quantification of endothelial proliferation after stretch in in YAP, TAZ, YAP/TAZ and VE-
Cadherin knockdown cells and control. HUVECs were subjected to cyclic stretch for 24h and 
percentage of cells in S phase was determined by EdU pulsing and immunofluorescence staining. 
Graph shows the mean +/- SD of the fold change in percentage of S phase positive cells of stretched to 
non stretched cells for each knockdown condition. n= 5 independent experiments, > 100 cells counted 
per experiment per condition. p values were calculated using unpaired t-test. *, p<0.05. 
 
2. YAP	and	TAZ	promote	individual	endothelial	cell	migration		
  
2.1. YAP/TAZ	promote	directional	cell	migration	
 
The analysis of Yap/Taz iEC-KO retinas suggested that a migration defect 
could be at play. Specifically, sprouting ECs lacking YAP/TAZ have less elongated 
nuclei and form a blunted sprouting front with fewer protrusions. Moreover, clumped 
nuclei in sprouts also suggest deficient migration and distribution of cells in space. 
 
To evaluate if YAP and TAZ regulate EC migration, I performed wound 
assays using HUVECs knocked down for YAP and/or TAZ (Figure 4.7 A-I). There, 
confluent ECs are induced to migrate towards a newly formed cell free “wound”. In 
control cells, the 500µm wound was always completely closed after 16hrs (Figure 
4.7 A, B, I). At the same time point, less than 50% of the wound area was closed 
after knockdown of YAP (47+/- 16% wound closure, p<0.0001) (Figure 4.7 C, D, I). 
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The knockdown of TAZ (Figure 4.7 E, F, I) and YAP/TAZ combined (Figure 4.7 G, 
H, I) has a stronger impact on cell migration, with less then 20% of the wound being 
closed at 16hrs (17+/-24% for siTaz, p<0.0001 and 18+/- 15% for siYap+siTaz, 
p<0.0001).  
 
Figure 4.7. YAP/TAZ promote cell migration 
A-H, Phase contrast images of YAP (C, D), TAZ (E, F) and YAP/TAZ (G, H) knockdown 
HUVECs and control cells (A, B) immediately after removing barrier to create a cell free space (A, C, E, 
G) and 16 hrs later (B, D, F, H). I, Wound closure at 16 hrs. Data are mean +/- SD of 3 independent 
experiments (8-9 biological replicates). p values were calculated using unpaired t-test between knocked 
down cells for YAP, TAZ or YAP/TAZ and control. ****, p<0.0001. 
 
 
2.2. YAP/TAZ	decrease	cell-cell	coupling	with	neighbouring	cells,	 favouring	positional	
rearrangements	
  
While doing these experiments, I observed that at the same time as control 
cells displayed the classic cobblestone appearance of HUVECs, cells knocked down 
for YAP and TAZ combined arranged in the monolayer into swirls (Figure 4.8 A, B). 
Looking into the literature, I found recent data illustrating that collectively migrating 
ECs in vitro move in streams and swirls, displaying straight junctions along the lateral 
boundaries and fingers along the front and rear (Hayer et al., 2016). This suggested 
that the organisation of cells in the monolayer could be used as a readout for 
collective cell migration, in opposition to the wound assay that informed on directional 
cell migration. To analyse this effect I collaborated with Dr. Silvanus Alt who 
developed a measure of monolayer coordination based on the alignment of cells with 
their neighbours. As a proxy for the orientation of each cell we used the longest axis 
of the nucleus obtained from a DAPI staining (Figure 4.8 C, D, C’, D’). A score of 1 
would signify parallel alignment between all cells, and a score of 0 random alignment 
of the population (Figure 4.8 E). Control cells displayed higher than random 
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alignment with their closest neighbours, but were arranged at random when distant 
by more than 300µm (Figure 4.8 F). While the knockdown of YAP did not affect the 
alignment score of cells, the knockdown of TAZ led to increased alignment. The 
combined knockdown of YAP/TAZ led to an even higher degree of coordination, with 
higher alignment scores across all distances between cells. These results suggest 
that YAP/TAZ promote the ability of cells to distribute individually within monolayers. 
Although YAP showed no difference in the alignment score of cells, this approach 
cannot exclude that also YAP knockdown cells show a defect in rearranging 
positions with the neighbours. A more conclusive experiment would be to perform 
time-lapse imaging of live HUVECs and analysing their positions in the monolayer 
over time.  
 
Figure 4.8. YAP/TAZ favour positional rearrangements 
A, B, Phase contrast images of YAP/TAZ knockdown monolayer of HUVECs (B) and control 
cells (A).  
C, D, Fluorescence labelling of nuclei with DAPI of YAP/TAZ knockdown monolayer of 
HUVECs (D) and control (C). C’, D’, Longest axis of nuclei in C,D. Scale bar: 100mm. 
E, Alignment score between nuclei pairs used for quantification of cell coordination in F. Angles 
made by the nuclei longest axis of a pair of nuclei were calculated; angles of 0, 45 and 90 degrees 
scored 1,0 and -1 in alignment. F, Coordination plot of monolayers of HUVECs knocked down for YAP, 
TAZ, YAP and TAZ and control. Graph shows mean alignment score of all pairs of cells in the 
monolayer plotted against distance between them. Randomly aligned cells score 0 in mean alignment. 
n= 3 independent experiments, >10.000 pairs of nuclei analysed per knockdown condition per 
experiment. 
 
Together, these experiments suggest that YAP/TAZ are essential for ECs to 
migrate in an individual way. In vivo, this could relate to how ECs migrate in sprouts 
– in the direction of the hypoxic tissue, instructed by growth factors, at the same time 
as shuffling positions with neighbouring ECs. 
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3. YAP	and	TAZ	regulate	endothelial	adherens	junctions	
 
3.1. YAP/TAZ	decrease	endothelial	permeability	
  
As shown before, the endothelial deletion of YAP and TAZ leads in the 
developing vasculature to a loss of vascular integrity in the sprouting front, with large 
haemorrhages. The maintenance of vascular integrity highly depends on the status 
of junctions between ECs (Dejana et al., 2008). However, it can also be affected by 
reasons external to ECs, as for example deficient mural cell coverage (Armulik et al., 
2010, Hellstrom et al., 2001). Although my results did not show deficient mural cell 
coverage in YapTaz iEC-KO vessels, they did show that the pericytes in YapTaz 
iEC-KO sprouting vessels abnormally express αSMA. Therefore, to directly test 
whether YAP and TAZ regulate endothelial permeability, I plated confluent YAP 
and/or TAZ knockdown cells on a semi-permeable membrane and evaluated the 
monolayers’ permeability to 250kDa dextran molecules. By doing so, I found that 
only the combined knockdown of YAP/TAZ led to a significant increase in 
permeability in comparison to the control situation (Figure 4.9). These results show 
that YAP/TAZ are required for the barrier function of the endothelium and can 
compensate for each other in this particular role.  
 
 
Figure 4.9. YAP/TAZ decrease endothelial permeability  
Permeability of YAP, TAZ and YAP/TAZ knockdown monolayers of HUVECs to 250kDa 
fluorescent dextran molecules. Data are mean ± SD of 3 independent experiments. p values were 
calculated using unpaired t-test between knocked down cells for YAP, TAZ and YAP/TAZ and control. *, 
p<0.05. 
 
3.2. YAP	 and	 TAZ	 promote	 the	 formation	 of	 junction	 associated	 intermediate	
lamellipodia	
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Several of the results shown so far suggest that YAP/TAZ regulate junctional 
remodelling. Yap/Taz iEC-KO retinas display increased unicellular vessel tubes, 
signifying loss of cellular rearrangements, which previous studies have shown to rely 
on remodelling of adherens junctions (Sauteur et al., 2014). Moreover, Yap/Taz iEC-
KO retinas display vessel crosses at the sprouting front, suggestive of failed 
anastomosis, that can also be caused by junctional remodelling defects (Lenard et 
al., 2013). Furthermore, the loss of endothelial YAP/TAZ leads to vessel bleedings in 
vivo and increased monolayer permeability in vitro, a hallmark of junctional 
dysfunction. Finally, YAP/TAZ promote cell migration, which is deeply linked to 
junctional remodelling. For all these reasons, I decided to investigate if YAP and TAZ 
regulate adherens junctions.  
 
To do so, I performed immunostainings for VE-Cadherin, the main component 
of endothelial adherens junctions, in YAP, TAZ and YAP/TAZ knockdown HUVECs. 
This approach revealed altered junctional morphologies in cells deficient for YAP and 
TAZ in comparison to control cells (Figure 4.10 A-D). Importantly, the morphology of 
adherens junctions has previously been correlated with its function. Although the 
earliest observations were performed in vitro and correlated the morphology of 
junctions only with permeability, later studies found similar morphologies in vivo and 
other readouts were investigated as well. In the mouse retina, straight (or linear) 
junctions were associated with high Notch activity and stalk cell behaviour, while VE-
Cadherin fingers (or serrated junctions) were more often found in tip cells or actively 
rearranging cells (Bentley et al., 2014). In vitro, activation of EC monolayers with pro-
angiogenic molecules such as VEGF increases both the appearance of fingers and 
the permeability between cells. For this reason, straight junctions have been 
associated with a quiescent endothelium, while serrated junctions bearing VE-
Cadherin fingers have been associated with an activated, angiogenic endothelium, 
characterised by both increased migratory activity and permeability. Interestingly, 
VE-Cadherin fingers were also shown to steer migrating ECs and couple leader and 
follower cells in cell culture (Hayer et al., 2016). More recently, a newly described 
junction type named junction associated intermediate lamellipodia (JAIL) (Abu Taha 
et al., 2014), that morphologically appears as reticular and broad shaped, has been 
observed in the sprouting vessels of the mouse retina (Cao et al., 2017). In culture, 
JAILs have been linked to increased migration (Cao et al., 2017) and decreased 
permeability of ECs (Breslin et al., 2015). 
In order to describe the immunofluorescence data in the most unbiased way 
possible, I defined five junctional categories that included all the morphologies I 
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found: straight junctions, thick junctions, thick to reticular junctions, reticular junctions 
and fingers (Figure 4.10 E). Live imaging analysis of VE-Cadherin-GFP transduced 
HUVECs confirmed that reticular junctions correspond to junction associated 
intermediate lamellipodia (JAIL), and showed that thick to reticular junctions 
correspond to small JAIL (Supplementary video 4.1). Additionally, the observation 
of live junctions also revealed that junction morphologies are very dynamic and the 
categorical junction types change between one another with time. In my static data, 
while control cells presented mostly reticular junctions (Figure 4.10 A, F), the 
knockdown of YAP and TAZ led respectively to an increase in straight junctions and 
fingers (Figure 4.10 B, C, F). The combined knockdown of YAP/TAZ led to an 
increase in both straight junctions and fingers and to a loss of reticular junctions 
(Figure 4.10 D, F). Moreover, the knockdown of YAP/TAZ led to junctional breaks in 
the monolayer, as seen by the presence of gaps in VE-Cadherin stainings (Figure 
4.10 D, red arrowheads). Together, these observations demonstrate that YAP and 
TAZ together are required for the formation of JAIL and reduce the formation of 
straight junctions and fingers. 
 
 
Figure 4.10. YAP/TAZ promote the formation of junction associated intermediate 
lamellipodia  
A-D, HUVECs knocked down for YAP (C), TAZ (D) and YAP/TAZ (E) and control cells (B) 
stained for VE-Cadherin. Red arrowheads, discontinuous VE-Cadherin. Scale bar: 50µm.  
E, Representative patches used for manual morphological classification of adherens junctions 
in 5 categories: straight junctions, thick junctions, thick to reticular junctions, reticular junctions and 
fingers.  
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F, Morphological classification of VE-Cadherin labelled cell junctions in HUVECs knocked 
down for YAP, TAZ and YAP/TAZ. Data are mean percentage ± SD of 3 independent experiments (2 for 
siTAZ). n> 140 patches of VE-Cadherin stained HUVECs per knockdown condition per experiment. p 
values were calculated using unpaired t-test between knocked down cells for YAP, TAZ and YAP/TAZ 
and control. *, p<0.05; **, p<0.01. 
 
 
3.3. YAP	and	TAZ	increase	the	turnover	of	endothelial	adherens	junctions		
 
Sprouting ECs are extremely dynamic. They migrate, undergo cell shape 
changes and swap positions with neighboring cells. All these rearrangements require 
cell-cell junctions that allow endothelial movement but at the same time ensure the 
maintenance of vessel integrity, which depends on the constant assembling and 
disassembling of molecular bonds. To understand if YAP and TAZ regulate the 
turnover of cell junctions, I performed pulse chase immunofluorescence experiments 
(Figure 4.11 A, B). Briefly, I pulse-labeled VE-Cadherin molecules at the cell 
junctions of live cells using an antibody directly coupled to a fluorescent dye for 30 
minutes (Dorland et al., 2016). Subsequently I washed out the antibody and cultured 
the cells for two more hours in normal conditions, allowing for the relocation of the 
pulsed antibody with the normal recycling of VE-Cadherin. At the end of this period I 
fixed the cells and stained for surface VE-Cadherin using a second fluorescent label. 
Comparing the two sequential VE-Cadherin labels allowed me to distinguish 
junctions with high, intermediate and low turnover rates (Figure 4.11 C). In control 
cells, 44% of patches were of high turnover junctions, 24% of intermediate turnover 
junctions and 32% of low turnover junctions (Figure 4.11 D). The knockdown of 
YAP/TAZ significantly decreased the percentage of high turnover junctions to 14% 
(p=0.0387) and increased the percentage of low turnover junctions to 58%. 
Interestingly, when coupling this analysis with the categorization of junction 
morphologies, I uncovered a correlation between the morphology of junctions and 
VE-Cadherin turnover rates (Figure 4.11 E, see pattern for siCTR). My results show 
that straight junctions and fingers are the junctions with lowest turnover, while 
reticular junctions (corresponding to JAIL) show the highest turnover. This was not 
surprising considering that JAIL are very dynamic junctions associated with 
lamellipodia activity. To understand if the different VE-Cadherin turnover observed 
after knockdown of YAP/TAZ was caused by a shift in morphology, I compared the 
turnover of VE-Cadherin within the same morphological categories (Figure 4.11 E). 
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Knockdown of YAP/TAZ decreased the percentage of high turnover junctions within 
all morphological categories, confirming a specific defect in VE-Cadherin turnover. 
 
 
Figure 4.11. YAP/TAZ increase the turnover of adherens junctions 
A, B, HUVECs knocked down for YAP/TAZ (B) and control (A) triple labelled with DAPI (blue), 
pulsed VE-Cadherin 55-7HI (red, VE-Cadherin pulse), and surface VE-Cadherin (green, VE-Cadherin 
staining). VE-Cadherin 55-7HI pulse was done for 30 minutes and cells were fixed 2 hours after end of 
pulse. Scale bar: 20µm. C, Representative patches used for manual classification of junctions into high, 
intermediate and low turnover. D, Junctional turnover in YAP/TAZ knockdown HUVECs and control 
cells. E, Percentage of high turnover junctions in each morphological category in YAP/TAZ knockdown 
cells and control. D, E, Data are mean ± SD of 3 independent experiments. n> 70 patches per 
knockdown condition per experiment. Fewer then 5 patches were reticular in YAP/TAZ knockdown, not 
allowing for reliable assessment of percentages between high, intermediate and low turnover. p values 
were calculated using unpaired t-test. *, p<0.05. 
 
3.4. YAP/TAZ	decrease	the	immobile	fraction	of	VE-Cadherin	at	the	cell	junction	
 
To validate these results and further investigate how YAP/TAZ affect the 
turnover of VE-cadherin, I used an approach similar to fluorescence recovery after 
photobleaching (FRAP), a well-established and quantitative method of measuring 
movement of molecules within the cell. In endothelial monolayers where cells are 
very dynamic, FRAP suffers from uncertainty caused by the movement of junctions. 
To overcome this limitation I used VE-Cadherin tagged with the photoconvertible 
molecule mEos, which allowed me to quantify the loss of fluorescence after 
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conversion of a subset of molecules, while monitoring the location of the junctions 
with the unconverted molecules (fluorescence loss after photoconversion, or FLAP). 
Because of the differences in turnover between junction morphologies uncovered 
before, only straight junctions were analysed in this experiment. Using this method, I 
observed an increase in the immobile fraction of VE-Cadherin at the junctions after 
YAP/TAZ knockdown (Figure 4.12 A), while no difference was seen for the half-time 
of fluorescence loss of the mobile fraction (Figure 4.12 B).  
 
 
Figure 4.12. YAP/TAZ decrease the immobile fraction of VE-Cadherin at adherens 
junctions 
A, B, Fluorescence loss after photoconversion of VE-Cadherin mEos in straight junctions of 
YAP/TAZ knockdown HUVECs and control HUVECs. A, VE-Cadherin mEos immobile fraction. B, VE-
Cadherin mEos half-life of fluorescence loss. Data are mean ± SD of 3 independent experiments. n= 15 
control cells and 16 cells YAP/TAZ knockdown cells. p values were calculated using unpaired t-test 
between knocked down cells for YAP/TAZ and control. ns, p>0.05; **, p<0.01. 
 
Together, these results show that YAP/TAZ increase the turnover of 
adherens junctions by increasing the pool of mobile VE-Cadherin. 
 
 
3.5. YAP/TAZ	regulate	the	actin	cytoskeleton		
 
To investigate if YAP and TAZ regulate the actin cytoskeleton I performed 
immunofluorescence staining for filamentous actin (F-actin) in YAP/TAZ deficient 
HUVECs and control cells. While control cells present junctional actin, stress fibers 
and branched actin (Figure 4.13 A, A’), YAP/TAZ deficient cells (Figure 4.13 B, B’) 
mostly display F-actin in stress fibers, low junctional actin and no branched actin 
networks. This result correlates with the junctional morphologies observed before, as 
fingers associate with stress fibers (Abu Taha and Schnittler, 2014), while JAILs 
associate with branched actin (Abu Taha et al., 2014). Interestingly, the VE-Cadherin 
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pulse labeling experiments showed that the junction morphologies with less turnover, 
straight junctions and fingers, were the ones associated with bundled actin filaments, 
while the morphologies with higher turnover, reticular junctions, associated with 
branched actin networks, raising the questions as to whether f-actin association 
impacts the turnover of adherens junctions. 
 
 
Figure 4.13. YAP/TAZ regulate the actin cytoskeleton in endothelial cells 
A, B, HUVECs knocked down for YAP/TAZ (B) and control (A) double stained for VE-Cadherin 
(red) and f-actin (green, phalloidin). A’, B’, f-actin (black, phalloidin). Scale bar: 50µm. 
 
4. Summary	and	conclusions	
 
In this chapter I have shown that YAP/TAZ regulate endothelial cell numbers 
by promoting endothelial proliferation in response to mechanical stretch, a response 
depend on YAP but not on TAZ. Moreover, YAP/TAZ promote endothelial cell 
migration and decrease endothelial permeability. At the cell junctions, YAP/TAZ 
favour the presence of junction associated intermediate lamellipodia, which are the 
junction type showing highest turnover.  
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Chapter	 5:	 Recovery	 of	 JAIL	 formation	 through	 BMP	
signalling	 rescue	 improves	 the	 migratory	 and	 permeability	
defects	caused	by	YAP	and	TAZ	deficiency	
  
1. Introduction	
 
In the previous chapter I presented my findings on cellular and molecular 
defects caused by the loss of YAP/TAZ in ECs. In this chapter I will describe how 
some of these defects can be attributed to abnormal BMP signalling. 
 
2. YAP	and	TAZ	repress	BMP	signalling	in	sprouting	endothelial	cells	
 
2.1. YAP	and	TAZ	repress	BMP	signalling	in	HUVECs	
  
In order to investigate possible signalling pathways downstream of 
endothelial YAP/TAZ I used in vitro luciferase assays. In an attempt to mimic the 
different activation status of YAP/TAZ in the vasculature (more nuclear at the 
sprouting front and more cytoplasmic in the remaining plexus), I assayed cells in 
different confluency conditions. In vitro, ECs display more often nuclear YAP/TAZ 
when sparse than when confluent (Figure 5.1 shows an example for TAZ; similar 
regulation is present also for YAP).  
 
 
Figure 5.1. Sparse cells have increased nuclear TAZ 
A, HUVECs plated at increasing cell densities were on the following day imaged by phase 
contrast, and fixed and stained for TAZ protein (white) by immunofluorescence and DAPI labelling (not 
shown). B, Quantification of subcellular location of TAZ protein in HUVECs seeded at increasing cell 
densities. Nuclear, intensity in nucleus/ intensity in cytoplasm >1.2; N and C, intensity in nucleus/ 
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intensity in cytoplasm 0.8-1.2; Cytoplasmic, intensity in nucleus/ intensity in cytoplasm <0.8. Results are 
from one representative experiment. 
 
Because of toxicity, it was not possible to achieve a fully confluent monolayer 
after double transfection with siRNAs and luciferase reporters; nonetheless, this 
approach was sensitive enough to pick up differences in signalling between sparse 
and subconfluent cells. The co-transfection of cells with siRNAs targeting YAP, TAZ 
or YAP/TAZ together with the TEAD luciferase reporter confirmed the applicability of 
this approach, showing a decrease in TEAD reporter activity in YAP, TAZ and 
YAP/TAZ knockdown HUVECs both in sparse and in subconfluent culture conditions 
(Figure 5.2 A, B). Canonical Wnt signalling, which promotes endothelial cell 
proliferation (Masckauchan et al., 2005) and vessel development (Phng et al., 2009), 
is not regulated by YAP/TAZ in HUVECs (Figure 5.2 C, D). Notch signalling on the 
other hand, which regulates tip-stalk cell specification and sprouting (Kofler et al., 
2011), is affected by the loss of YAP/TAZ, and curiously in opposite ways in sparse 
and subconfluent cells. While in sparse cells the knockdown of YAP/TAZ causes a ~ 
6 fold increase in RBP-J reporter activity (Figure 5.2 E), in subconfluent cells it leads 
to a ~3 fold decrease in RBP-J reporter activity (Figure 5.2 F). Finally, BMP 
signalling, another key pathway regulating sprouting angiogenesis (Dyer et al., 2014, 
Garcia de Vinuesa et al., 2016), was investigated using a BRE reporter. In sparse 
cells, the knockdown of YAP, TAZ and YAP/TAZ leads respectively to a ~6, ~10 and 
~50 fold increase in BRE reporter activity (Figure 5.2 G). In subconfluent cells the 
same direction of effect is seen, but approximately 5 times weaker than in sparse 
cells (~1.3, ~3 and ~9 fold increase in BRE reporter activity in YAP, TAZ and 
YAP/TAZ knockdown cells respectively) (Figure 5.2 H). 
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Figure 5.2. Endothelial YAP and TAZ repress BMP signalling in HUVECs 
A-H, Luciferase reporter assays in YAP, TAZ and YAP/TAZ knockdown HUVECs and controls. 
Assays were performed using Hippo (A, B), Wnt (C, D), Notch (E, F) and BMP (G, H) reporters both in 
sparse (A, C, E, G) and subconfluent (B, D, F, H) culture conditions. Data are mean +/- SD. p values 
were calculated using unpaired t-test. n≥ 6 experiments for Hippo reporter, ≥ 3 experiments for Wnt 
reporter (except for siTAZ, were n=2), ≥ 3 experiments for Notch reporter, 3 experiments for BMP 
reporter. *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001. 
I-K, Reverse transcriptase quantitative PCR in YAP, TAZ and YAP/TAZ knockdown HUVECs 
and control HUVECs for TEAD (I), Notch (J) and BMP (K) target genes. Results are relative to siCTR. 
RT-PCR normalisation was performed with HPRT expression. Data are mean +/- SD of 3 independent 
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experiments. p values were calculated using unpaired t-test. ns, non significant, p>0.05; *, p<0.05; **, 
p<0.01; ***, p<0.001; ****, p<0.0001.  
 
The results with the BRE reporter were confirmed by RT-qPCR in sparse 
YAP/TAZ knockdown cells. As expected, YAP/TAZ knockdown cells show decreased 
expression of the TEAD target genes CTGF, CYR61 and ANKRD1 and INHBA1 
(Figure 5.2 I). As for Notch target genes, YAP/TAZ knockdown cells express more 
LFNG, DLL4 and HEY1; the expression of NRARP and HES1 is not changed (Figure 
5.2 J). Finally, YAP/TAZ knockdown cells express more of the BMP target genes 
SMAD6 and UNC5B, but not ID1 or ID3 (Figure 5.2 K). Importantly, significant 
crosstalk between Notch and BMP signalling exists in the vasculature (Beets et al., 
2013). Specifically, the transcription of HEY1 can also be induced by BMPs 
independently of Notch in ECs (Woltje et al., 2015), thus it is also here shown as a 
BMP target gene. 
 
2.2. YAP	and	TAZ	repress	BMP	signalling	in	the	sprouting	front	of	the	mouse	retina	
 
To understand if similar regulation was present in vivo I performed 
immunofluorescence stainings in Yap/Taz iEC-KO retinas. I evaluated Wnt signalling 
by staining for the Wnt/b-catenin nuclear effector LEF-1 (Figure 5.3 A, B). In both 
control and Yap/Taz iEC-KO retinas, LEF-1 signal is lowest at tip cells and in 
arteries, and highest in the remaining ECs. I found no difference between LEF-1 
signal intensity or location between control and Yap/Taz iEC-KO retinas, in line with 
the previous luciferase results. Evaluation of Notch signalling by 
immunofluorescence is hindered by the absence of a working NICD antibody, which 
would be the best readout for Notch activity. As DLL4 was upregulated in the qRT-
PCR analysis in YAP/TAZ knockdown HUVECs, I used this protein as the readout to 
assess Notch signalling in vivo (Figure 5.3 C, D). In the vasculature of the 
developing retina, DLL4 typically labels tip cells and arteries, and is absent from 
veins. A similar pattern of staining is present in Yap/Taz iEC-KO retinas, however the 
drop in intensity in DLL4 signal from tip to stalk cells is not as sharp as in control 
retinas, with a broader DLL4 signal area. Finally, I stained retinas for the BMP 
nuclear effector pSMAD1/5/8 (Figure 5.3 E, F). In control retinas, very little 
pSMAD1/5/8 signal is seen throughout the entire vasculature. In contrast, Yap/Taz 
iEC-KO retinas show increased pSMAD1/5/8 signal especially at the sprouting front. 
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Figure 5.3. pSMAD 1/5/8 is increased in YAP/TAZ iEC-KO retinas 
A-F, Retinas from P6 YapTaz iEC-KO (B,D,F) and respective control pups (A,C,E) were 
stained with Isolectin B4 (A-F, IB4) and with LEF1 (A,B magenta, A’, B’ grey), DLL4 (C,D magenta, C’, 
D’ grey) or pSMAD1/5/8 (E,F magenta, E’, F’ grey). Scale bar: 200µm.  
 
 
To confirm that this increase was endothelial I co-stained retinas for 
pSMAD1/5/8 together with the endothelial nuclear marker ERG and imaged retinas 
at higher resolution (Figure 5.4 A, B). Both in control and in Yap/Taz iEC-KO retinas 
pSMAD1/5/8 positive nuclei are found adjacent to the vasculature in ERG negative, 
non-ECs (Figure 5.4 A1, B1, yellow arrowheads). At the sprouting front of control 
retinas, 5 +/- 2.5% of ECs are positive for pSMAD1/5/8 (Figure 5.4 A2, C). In 
contrast, in Yap/Taz iEC-KO retinas 52+/-0.6%, of ECs are positive for pSMAD1/5/8 
(Figure 5.4 B2, C). Moreover, this effect is likely underestimated by the binary 
quantification that I performed, as the intensity of pSMAD1/5/8 in the nuclei of 
Yap/Taz iEC-KO ECs is also much higher than in control ECs. Together, the in vitro 
and in vivo results here presented clearly show that YAP/TAZ strongly repress BMP 
signalling in ECs at the sprouting front. 
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Figure 5.4. YAP/TAZ repress BMP signalling in sprouting endothelial cells 
A, B, P6 retinal vessels labelled with IB4 (blue) and stained for ERG (red, marking endothelial 
nuclei) and pSMAD1/5/8 (green) in YapTaz iEC-KO (B) and littermate control mice (A). Images 
correspond to single confocal planes. A1, A2, B1, B2, magnification of boxed areas in A and B. Yellow 
arrowheads, perivascular cells. White arrowheads, endothelial nuclei. Scale bar: A, B 50µm, A1, A2, B1, 
B2, 10µm. 
C, Percentage of ECs positive for pSMAD1/5/8 at the sprouting front of the P6 retina in YapTaz 
iEC-KO and littermate control mice (n=3 pups per condition). Data are mean ± SD. p values were 
calculated using unpaired t-test. ****, p<0.0001. 
 
BMPs (bone morphogenetic proteins) were first identified in the 1960s as 
inducers of ectopic bone formation, when demineralised bone matrix implanted in 
rabbit muscle gave rise to bone (Urist, 1965). Their recognised spectrum of action 
has since expanded, and nowadays BMPs are known to exert fundamental roles 
during the embryonic developmental of many organs and maintenance of 
homeostasis in the adult, so much so that some authors suggested their renaming as 
body morphogenetic proteins (Wagner et al., 2010). 
 
BMPs, or BMP ligands, are secreted proteins that belong to the TGFβ 
superfamily. Based both on their amino acid and nucleotide similarities and on 
affinities for different receptors they can be categorised into four subgroups: BMP 2/4 
subgroup, the BMP 5/6/7/8 subgroup, the BMP 9/10 subgroup and the BMP 12,13,14 
(or growth and differentiation factors 5,6,7) subgroup. BMP receptors have a short 
extracellular domain, a single transmembrane domain, and an intracellular domain 
with serine/threonine kinase activity. There are a total of seven type I receptors 
(ALK1-7) for the TGFβ family, four of which bind BMPs: type 1A BMP receptor 
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(BMPR-1A or ALK3), type 1B BMP receptor (BMPR-1B or ALK6), type 1A activin 
receptor (ActR-1A or ALK2) and ALK1. There are four type II receptors, three of 
which bind BMPs: type 2 BMP receptor (BMPR-2), type 2 activin receptor (ActR-2A), 
and type 2B activin receptor (ActR-2B). While BMPR-1A/ALK3, BMPR-1B/ALK6, and 
BMPR-2 are specific to BMPs, ALK1, ActR-1A, ActR-2A, and ActR-2B can function 
as receptors for activins, which are also members of the TGFβ superfamily. Most 
receptors are not specific for individual BMPs, which causes great combinatorial 
complexity of BMP ligand – receptor partners (Townson et al., 2012). 
 
In the canonical BMP signalling pathway, BMPs bind BMP receptors 
comprised of two type I receptor subunits and two type II receptor subunits. Upon 
ligand binding, the type II receptor trans phosphorylates the type I receptor, which 
then phosphorylates the immediate downstream substrate proteins known as 
receptor regulated Smads (R-Smad), Smad1, Smad5 and Smad8 (Smad1/5/8). 
Activated pSMAD1/5/8 complexes with the co-mediator Smad (co-Smad) Smad4 
translocating to the nucleus. There, together with other transcription factors, co-
activators and co-repressors, pSMAD1/5/8-Smad4 activate or repress target genes. 
Inhibitory Smads (I-Smads), Smad6 and Smad7 (Smad6/7), are involved in feedback 
inhibition of the signaling pathway. They inhibit the activation of R-Smads by 
competing for type I receptor interaction and by recruiting ubiquitin ligases or 
phosphatases to the activated receptor complex thereby targeting it for proteosomal 
degradation or dephosphorylation, respectively. BMP signaling can also occur 
through not canonical pathway, in which BMPs signal through MAPK kinases, PI3 
kinase/AKT, PKC and others (Zhang, 2009). 
 
Regulation of BMP signaling is achieved by a diverse number of extracellular, 
intracellular and membrane modulators. Extracellular modulators can be agonists or 
antagonists of BMP signaling; BMP antagonists bind BMPs thus preventing them 
from binding their cognate receptors (Walsh et al., 2010). Some BMP antagonists are 
the CAN (Cerberus and DAN) family of proteins, Twisted gastrulation, Chordin and 
Crossveinless 2, and Noggin. Intracellular regulators of BMP signaling include 
microRNAs, I-SMADS, phosphatases that dephosphorylate the BMP receptors and 
R-Smad, and FK506-binding protein 1A that binds type I receptors to inhibit receptor 
internalization. Co-receptors in the plasma membrane that interact with type I and 
type II receptors further add a level of regulation. Of particular interest for vascular 
biology, Endoglin is a co-receptor that has been shown to be important in vascular 
growth and disease (ten Dijke et al., 2008). Finally, crosstalk with other signaling 
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pathways, such as Notch, Wnt and Sonic hedgehog signaling, likely adds another 
layer of control. 
 
3. Partial	 rescue	 of	 BMP	 signaling	 in	 YAP/TAZ	 deficient	 cells	 improves	
cellular	defects	
 
3.1. Ldn193187	treatment	partially	rescues	the	BMP	signalling	defect	in	vitro	
 
Notch signalling plays a key role in the determination of tip and stalk cell 
identities in developing vessels. Too little Notch signalling, as seen in DLL4 or Notch 
1 mutants or by DAPT treatment, favours tip cell specification, leading to a 
hypersprouting phenotype with consequent increased vascular density (Suchting et 
al., 2007, Hellstrom et al., 2007, Lobov et al., 2007, Tammela et al., 2008). In 
contrast, too much Notch signaling reduces the number of tip cells and leads to a 
hyposprouting phenotype, with reduced branch points and vascular density (Benedito 
et al., 2009, Hellstrom et al., 2007). As the loss of YAP/TAZ causes a hyposprouting 
phenotype in vivo and increases Notch signaling in sparse cells in vitro, I 
hypothesized that too much Notch signaling could be driving the phenotype in 
Yap/Taz iEC-KO retinas. This hypothesis was however proven wrong by Gou Young 
Koh’s group, who showed that Notch inhibition in Yap/Taz iEC-KO retinas does not 
rescue the vascular defects (Kim et al., 2017). Moreover, the in vitro cellular 
phenotypes I unveiled were present in confluent YAP/TAZ knockdown cells, where 
the luciferase data shows a decrease instead of an increase in Notch signalling. This 
reason also suggests that the cellular defects of YAP/TAZ loss are not driven by an 
increase in Notch signalling. 
 
In contrast to Notch, the effect of YAP/TAZ on BMP signalling was much 
clearer and stronger. How BMP signalling affects the development of blood vessels 
is however not as straightforward. As presented before, there are multiple BMP 
ligands and receptors that can combine in different ways. Depending on the specific 
ligands and receptors involved, BMP signalling can either be pro or antiangiogenic. 
In the vasculature, the BMP9/BMP10-ALK1 axis supresses sprouting (Ricard et al., 
2012), thus, an increase in the activity of this axis could be a cause for the 
hyposprouting phenotype of YAP/TAZ mutant retinas. On the other hand, 
BMP2/BMP4 are considered pro-angiogenic molecules (Mishina et al., 2002), as well 
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as signalling through the Alk2 and Alk3 receptors (Lee et al., 2017). For this reason, 
an increase of BMP signalling through these ligands/receptors was not expected. 
 
To understand the contribution of the BMP signalling increase for the cellular 
defects caused by YAP/TAZ loss I attempted to rescue the signalling defect in 
YAP/TAZ knockdown cells. To do so, I treated cells with a panel of BMP inhibitors 
targeting different ligands or receptors (Figure 5.5 A). Moreover, this strategy 
presented the added benefit of dissecting the axis through with BMP signalling was 
increased in YAP/TAZ knockdown cells. Of all the drugs tested only Ldn193187, an 
Alk2/3/1 kinase inhibitor, significantly decreased the BMP reporter activity after YAP 
and TAZ knockdown (Figure 5.5 B). This decrease was however not a complete 
rescue: in YAP/TAZ knockdown cells the BMP reporter activity dropped from 12 
times higher when treated with DMSO to 7 times higher when treated with 
Ldn193187, in comparison to control cells. Contrary to the expectations, the use of 
ALK1-Fc and ENG-ecd, which primarily bind to and inhibit BMP9 and BMP10, did not 
affect the BMP signaling increase in YAP/TAZ knockdown cells. 
 
 
Figure 5.5. Ldn193187 treatment partially rescues the BMP signalling increase in 
YAP/TAZ deficient endothelial cells. 
A, Schematic of the BMP inhibitors used depicting preferential sites of inhibition. Alk1fc, 
ENGecd and Gremlin bind extracellular BMPs. K02288 and Ldn193189 are kinase inhibitors acting 
intracellularly.  
B, Luciferase reporter assay for BMP activity in YAP/TAZ knockdown HUVECs and controls 
treated with 25 ng/mL Alk1fc, 0.25µg/mL ENGecd, 0.1 µg/mL Gremlin, 1µM K02288, 1µM Ldn193189 
and DMSO. Data are mean ± SEM. p values were calculated using unpaired t-test. **, p<0.01; ****, 
p<0.0001. n≥3 biological replicates. 
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3.2. Ldn193187	treatment	increases	the	frequency	of	junction	associated	intermediate	
lamellipodia	 in	 YAPTAZ	 knockdown	 cells	 and	 improves	 the	 migration	 and	
permeability	defects	
  
Although Ldn193187 treatment only partially rescued the increase in BMP 
signalling in YAP/TAZ knockdown HUVECs, I investigated whether this was sufficient 
to affect the morphology of adherens junctions. To do so, I treated YAP/TAZ 
knockdown cells with Ldn193187 or DMSO and compared the morphology of VE-
Cadherin (Figure 5.6 A, B). Ldn193187 treatment decreased the frequency of finger 
junctions and increased the frequency of reticular junctions in YAP/TAZ deficient 
cells (Figure 5.6 A’, B’). Quantification of junction morphologies by blind analysis of 
patches revealed that Ldn193187 treatment decreased the frequency of finger 
junctions in YAP/TAZ deficient cells to levels comparable to control cells (Figure 5.6 
C and Figure 4.10 A, F) (% of fingers: siYAP/TAZ DMSO, 25+/-5%, siYAP/TAZ 
Ldn193187 12+/-0.6%, siCTR: 9+/-4%). Ldn193187 treatment also led to a 3-fold 
increase in thick to reticular and reticular junctions in YAP/TAZ knockdown cells. The 
frequency of straight junctions was also significantly decreased, although still 
remaining high in comparison to control cells. 
 
 
Figure 5.6. Ldn193187 treatment increases the frequency of junction associated 
intermediate lamellipodia in YAP/TAZ knockdown endothelial cells 
A, B, HUVECs knocked down for YAP/TAZ and treated with 1 µM Ldn193189 (B) or DMSO (A) 
were stained for VE-Cadherin. A’, B’, magnification of boxed areas in A, B. Red arrowheads, fingers. 
Red dashed line, reticular junction. Scale bar A, B, 50µm. Scale bar A’, B’, 10µm.  
C, Morphological analysis of VE-Cadherin labelled cell junctions in HUVECs knocked down for 
YAP/TAZ and treated with 1µM Ldn193189 or DMSO control. Data are mean ± SD. p values were 
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calculated using unpaired t-test. n= 3 biological replicates; n≥ 45 patches of VE-Cadherin stained 
HUVECs per condition per replicate.  
 
I then investigated whether Ldn193187 treatment affected the migratory 
capacity of YAP/TAZ knockdown HUVECs, as well as the barrier function of the 
monolayer. Ldn193187 treatment improves the migration defect of YAP/TAZ 
knockdown cells: in the scratch wound assay, the wound closure increases from 
33+/- 3% in DMSO treated cells to 56+/-5% in Ldn193187 treated cells (Figure 5.7 
A). Moreover, Ldn193187 treatment completely rescues the barrier defect of 
YAP/TAZ knockdown cells (Figure 5.7 B). These results show that at least partially 
the cellular and molecular defects of YAP/TAZ knockdown cells are caused by an 
increase in BMP signalling. As Ldn193187 treatment did not completely rescue the 
signalling defect it was not possible to completely understand how much of the 
cellular defects are in fact caused by increased BMP signalling. 
 
 
Figure 5.7. Ldn193187 treatment improves the migration and decreases the permeability 
in YAP/TAZ knockdown endothelial cells 
A, Wound closure at 16hrs for HUVECs knocked down for YAP/TAZ and treated with 1mM 
Ldn193189 or DMSO. Data are mean +/- SD. p values were calculated using unpaired t-test. **, p<0.01. 
n= 6-7 biological replicates. 
B, Permeability of HUVECs knocked down for YAP/TAZ and treated with 1µM Ldn193189 or 
DMSO to 250kDa fluorescent dextran molecules. Data are mean +/- SD. RFU, relative fluorescence 
units. p values were calculated using unpaired t-test. ****, p<0.0001. n = 6 biological replicates. 
 
4. YAP/TAZ	increase	the	transcription	of	BMP	inhibitors	
 
An increase in BMP signaling can be a consequence of an increase in BMPs, 
BMP receptors/co-receptors or a decrease in BMP antagonists (Figure 5.8 A). To 
understand at what level of regulation YAP/TAZ affect BMP signaling I investigated 
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the expression of these components in YAP/TAZ knockdown cells. The knockdown 
of YAP/TAZ causes a decrease in the expression of BMP4 in ECs, which however 
cannot be the cause for the increased BMP signaling (Figure 5.8 B). The expression 
of BMP2 and BMP6 is not affected and that of BMP7 and BMP9 is too low for 
detection in HUVECs. The knockdown of YAP/TAZ does not affect the expression of 
the BMP receptors ALK1, ALK2, ALK5, ALK6, BMPR2 and of the co-receptor ENG 
(Figure 5.8 C); the expression of ALK3 is too low for detection in HUVECs. 
Interestingly, the knockdown of YAP/TAZ leads to a strong decrease in the 
expression of the BMP antagonists CTGF, NOG and FST, and to a milder but also 
significant decrease in the expression of FSTL1, SMURF1 and SMURF2 (Figure 5.8 
D). Other BMP antagonists as BMPER and BAMBI are not affected by YAP/TAZ loss 
in HUVECs. These results suggest that the increase in BMP signaling in the context 
of YAP/TAZ loss of function can be due to a loss of BMP antagonists. Furthermore, 
as YAP/TAZ act as transcriptional co-activators when in the nucleus, meaning that 
they promote the transcription of genes and do not act as transcriptional repressors, 
this results fits with the possibility of a direct transcriptional effect of YAP/TAZ on 
BMP antagonists.  
Together, these results suggest that YAP and TAZ repress BMP signalling in 
ECs by increasing the expression of BMP inhibitors. 
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Figure 5.8. YAP/TAZ increase the expression of BMP antagonists in endothelial cells 
A, Schematic of the main BMP signaling components. 
B-D, RT-qPCR in YAP/TAZ knockdown HUVECs and control cells for BMPs (B), BMP 
receptors and co-receptors (C) and BMP antagonists (D). Results are relative to siCTR. Normalisation 
was performed with GAPDH expression. No amplification of the cDNA of BMP7, BMP9 and ALK3 was 
obtained. Data are mean ± SD of 7 biological replicates from 3 independent experiments. p values were 
calculated using unpaired t-test. ns, p>0.05; *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001. 
 
5. Summary	and	conclusions	
 
In this chapter I have shown that endothelial YAP/TAZ repress BMP signaling 
in sprouting ECs likely by increasing the expression of secreted BMP antagonists 
such as CTGF and NOG. In ECs, the repression of BMP signaling increases the 
formation of JAILs, promotes cell migration and decreases permeability. 
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Chapter	6	–	Discussion	and	future	perspectives	
 
 
When this study started very little was known of the role of the Hippo pathway 
effectors YAP and TAZ on the biology of ECs, and particularly during sprouting 
angiogenesis. Because of the critical roles discovered for YAP and TAZ in the 
development of other tissues and organs, a lot of attention from the angiogenesis 
community was put into unravelling their roles in the endothelium. These efforts 
culminated with the publication of a series of papers in the last half of 2017 – first half 
of 2018, including my own paper. Here, I will discuss the results of my discoveries 
and place them in the overall field of YAP/TAZ in endothelial biology and 
angiogenesis.  
 
4. Summary	of	the	findings	
 
YAP and TAZ are both expressed in ECs. While in quiescent vessels they are 
only present in the cytoplasm, they are nuclear in a few ECs of actively sprouting 
vessels. This pattern of expression is accompanied by a functional role during 
sprouting angiogenesis. YAP/TAZ are necessary for the new blood vessels to grow 
and cover the hypoxic tissue. Without YAP/TAZ fewer sprouts are formed; the 
sprouts are rounder, lack cellular protrusions and are haemorrhagic. The vasculature 
formed is smaller, less dense, with fewer connections and less homogeneous, and 
abnormal crosses between arteries and veins and between capillaries are formed. 
YAP and TAZ show a high degree of redundancy, which is better illustrated by the 
striking phenotype of the double mutant in comparison with the single mutants. 
Nonetheless, they also show unique characteristics. In vivo, while YAP preferentially 
locates to the cytoplasm, TAZ preferentially locates in the nucleus. Only TAZ single 
mutants show hyposprouting, AV crosses and vein defects. 
I found several cellular functions of YAP and TAZ that seem to account for 
the phenotype of the YAP/TAZ iEC-KO mutants. First, YAP/TAZ promote endothelial 
cell proliferation, which is essential to provide new cells to the growing vascular 
tissue. Specifically, I found that YAP is necessary for stretch-induced proliferation of 
ECs, but not for VEGF-induced proliferation. I propose that this represents a cell 
intrinsic way of controlling cell densities, in contrast to the more widespread 
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proliferation that happens in response to growth factor signalling. Second, YAP/TAZ 
promote cell migration and rearrangements of cells, necessary during the formation 
of new sprouts and anastomosis of vessels. Third, YAP/TAZ decrease endothelial 
permeability, thereby preventing haemorrhages. Molecularly, YAP/TAZ regulate the 
architecture and turnover of VE-Cadherin adherens junctions, promoting the 
formation of JAILs. In this way, YAP/TAZ not only are required to provide the correct 
number of ECs for the growing vasculature, they also ensure that ECs are correctly 
distributed, thereby achieving the right number of ECs in the right place. 
YAP/TAZ strongly repress BMP signalling in actively sprouting ECs likely by 
promoting the transcription of secreted BMP inhibitors. In particular, I show that BMP 
signalling repression is required to limit endothelial permeability and for ECs to form 
JAILs. 
 
5. Regulation	of	YAP	and	TAZ	in	the	endothelium		
 
YAP/TAZ are commonly found in the nucleus of epithelial cells located in 
actively proliferating areas of developed and developing tissues. In contrast, 
quiescent tissues display cytoplasmic, transcriptionally inactive YAP/TAZ, and 
frequently in those the re-location of YAP/TAZ to the nucleus is seen and plays a role 
during inflammation or neoplastic transformation. Through my work I have found that 
a similar regulation is present in ECs of developing blood vessels: more mature, 
quiescent vessels uniformly display inactive YAP/TAZ, while actively sprouting 
vessels show a more dynamic expression of active YAP/TAZ.  
How this is regulated in ECs is not entirely clear. ECs at the sprouting front 
and in quiescent vessels show various differences that could account for this 
regulation. Distinct adherens junctions, basement membrane and coverage by 
pericytes; distinct levels of signalling from secreted angiogenic molecules; different 
levels of shear stress by blood flow; different levels of pulling and pushing forces 
from migrating neighbouring cells.  
In vitro, endothelial YAP and TAZ relocate to the nucleus upon disruption of 
cell junctions or loss of VE-Cadherin (Choi et al., 2015). In the mouse retina 
vasculature, it was recently shown that ECs at the sprouting front display reduced 
VE-Cadherin concentration than more mature vessels (Cao et al., 2017). In addition 
to the concentration of VE-Cadherin being different, adherens junctions at the 
sprouting front are activated, more permeable, and displaying increased finger 
junctions (Bentley et al., 2014) and JAILs (Cao et al., 2017). These differences nicely 
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correlate with my data showing the sprouting front as the area of preferential nuclear 
YAP/TAZ, and suggest that similarly to other cell types the subcellular location of 
YAP/TAZ is regulated by the status of adherens junctions.  
Some studies point to YAP/TAZ being regulated by shear stress. Nakajima 
and colleagues (Nakajima et al., 2017) showed that in the zebrafish YAP nuclear 
relocation correlated with lumenisation of sprouting vessels, which was attributed to 
the effect of shear stress on YAP. In the mouse retina, hemodynamic fluid laws 
predict that vessels at the sprouting front experience very low levels of shear 
(Bernabeu et al., 2014), arguing against YAP and TAZ being activated by shear in 
this model. Additionally, I found no difference in the subcellular localisation of YAP or 
TAZ between arteries and veins, i.e. vessels that experience distinct shear stress 
levels. However, it is possible that local and fast changes in shear stress levels are 
more relevant to regulate YAP and TAZ than sustained shear. In support of this idea, 
YAP and TAZ appear not to respond to 12 or 24h of laminar shear (Wang et al., 
2016), but translocate to the nucleus after only 10 minutes of laminar shear 
(Nakajima et al., 2017). In addition to shear, ECs are subjected to pushing and 
pulling forces from neighbouring cells, especially at the sprouting front where they 
undergo cell migration towards the source of pro-angiogenic molecules. In this 
regard, I have shown that YAP is required for stretch induced proliferation, 
highlighting this mechanical stimuli as a regulator for the function of YAP. In epithelial 
cells, YAP was further shown to relocate to the nucleus upon application of cyclic 
stretch(Benham-Pyle et al., 2015), suggesting that a similar mechanism could be 
present in ECs.  
As YAP/TAZ are also regulated by growth factors in other cell types, I tested 
if VEGF, a crucial driver of endothelial proliferation and migration, was upstream of 
YAP/TAZ in ECs. Although I found no evidence for this, four independent labs (Kim 
et al., 2017, Wang et al., 2017, Azad et al., 2018, He et al., 2018) published evidence 
for VEGF-VEGFR2 signalling being upstream of YAP/TAZ activation, including one 
unbiased screen for upstream regulators of the Hippo pathway from one non-
angiogenesis lab. Their combined data thus support a model in which VEGF 
signalling critically regulates YAP/TAZ subcellular location, and because VEGF is 
produced ahead of the growing vessels, it fits with the nuclear location of YAP/TAZ at 
the sprouting front. Differently, my proliferation experiments suggest that cells 
deficient for YAP/TAZ are even more sensitive to VEGF. Interestingly, CTGF, a 
secreted molecule downstream of YAP/TAZ-TEAD signalling, was shown to directly 
bind extracellular VEGF thereby preventing its downstream signalling (Inoki et al., 
2002), which could explain the apparent increased sensitivity of YAP/TAZ deficient 
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cells to VEGF. Apart from VEGF, the effect of other pro-angiogenic molecules, either 
locally produced or blood-borne, was not yet addressed, and could prove in the 
future to regulate endothelial YAP and TAZ during development. Future work will 
help clarify these questions and how different chemical and mechanical stimuli come 
together to regulate YAP and TAZ. 
 
6. The	balance	between	migration	and	permeability	during	the	sprouting	of	
new	vessels	
 
Among all the pro-angiogenic molecules known, VEGF is arguably the most 
critical. The requirement of VEGF for blood vessel development is readily illustrated 
by the early embryonic lethality and abnormal vessel formation of even the 
heterozygous VEGF deletion (Carmeliet et al., 1996, Ferrara et al., 1996). VEGF is 
produced and secreted by the hypoxic tissue and upon binding to its cognate 
receptors on ECs activates them to start sprouting new vessels. Importantly, during 
sprouting angiogenesis, VEGF increases both EC migration and permeability. These 
well-established roles of VEGF have contributed to the concept of inactive and active 
junctions in the endothelium: while stable, quiescent blood vessels display inactive 
adherens junctions that limit endothelial motility and maintain the vessel 
impermeable, ECs undergoing angiogenesis display activated adherens junctions 
that allow increased endothelial motility and are characterized by increased 
permeability. Thus, my results showing that YAP/TAZ increase both migration and 
decrease permeability were at first surprising. However, it is conceivable that 
YAP/TAZ at the sprouting front is necessary to balance the VEGF induced increased 
permeability of new sprouts. Interestingly, data from recent years has revealed that 
sprouting ECs do not migrate in a head to toe fashion, but instead can swap 
positions with their neighbours (Jakobsson et al., 2010). While doing so, ECs 
maintain cell-cell contacts, which requires the formation of new junctions and 
resolution of the old ones(Blum et al., 2008, Jakobsson et al., 2010, Lenard et al., 
2013). Additionally, observations in the zebrafish and mouse showed that a perfused 
lumen is already present in the nascent sprout reaching the tip cell, propelled by the 
pressure of blood (Gebala et al., 2016) – unlike the previous idea that tip cells were 
not subjected to the effect of blood pressure. These new findings illustrate the 
importance of tightly balancing the permeability while allowing the migration of the 
very dynamic, pressure subjected ECs in sprouts, so that bleedings can be 
prevented.  
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The opposite effects on endothelial permeability between VEGF and 
YAP/TAZ seem to be explained by the type of adherens junctions they promote: 
while VEGF induces the formation of finger junctions (Monaghan-Benson and 
Burridge, 2009), YAP/TAZ induce the formation of JAILs, which were previously 
shown to decrease endothelial permeability (Breslin et al., 2015).  
JAILs were first described in cultured ECs in 2014(Abu Taha et al., 2014), 
and they were first observed in ECs in vivo at the sprouting front, suggesting an 
important role there (Cao et al., 2017). Interestingly, JAILs both decrease 
permeability and increase migration. I suggest that the reason for this relies on the 
organisation and fast half-life of JAILs and on the fast turnover of the VE-Cadherin 
molecules within JAILs. When two ECs are connected via finger junctions in culture, 
a long extension of contacting cell membrane is devoid of VE-Cadherin; gaps 
between the cell bodies can also occur – all this accounting for increased 
paracellular permeability. In contrast, when two ECs are connected by JAILs, their 
cell bodies are connected by many VE-Cadherin molecules covering the large 
extension of the lamellipodia – thus decreasing permeability. While this is so, the 
JAIL is very short-lived and VE-Cadherin molecules show fast turnover, which means 
that the molecular bonds between touching cells are quickly formed and resolved – 
allowing for increased cell movements.  
 
7. YAP/TAZ	and	adhesive	junctions	
In addition to nuclear and cytoplasmic YAP and TAZ, I also observed 
junctional localization of these proteins in retinal vessels. A previous study by 
Giampietro and colleagues (Giampietro et al., 2015) has shown that endothelial YAP 
associates with adherens junction proteins at stable junctions and that this prevents 
its nuclear accumulation and transcriptional activity. Similarly, the disorganisation of 
VE-Cadherin bonds by calcium chelation or the loss of VE-Cadherin protein by gene 
knockdown were shown to cause the relocation of YAP to the nucleus (Choi et al., 
2015). Curiously, a recent publication reported that, in the mouse retina, sprouts 
have relatively less VE-Cadherin than more mature vessels with stable junctions 
(Cao et al., 2017), which fits with the area of nuclear YAP/TAZ. Moreover, I did not 
find junctional YAP or TAZ at the sprouting front, suggesting that activated junctions 
fail to sequester YAP/TAZ. Conceptually, these data support the hypothesis that the 
subcellular location of YAP/TAZ in the vasculature is at least in part regulated by the 
maturation of adherens junctions. Importantly, my work now adds that, in turn, 
YAP/TAZ also regulate adherens junctions. YAP/TAZ promote the formation of 
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JAILs, which are very dynamic and fast turnover adherens junctions. This is 
mediated through BMP signalling repression via transcription of YAP/TAZ 
antagonists, therefore represents a nuclear role of YAP/TAZ. Interestingly, this 
finding corroborates recent findings in mouse hepatocytes where YAP antagonises 
adherens junction stability (Bai et al., 2016). The authors showed that YAP regulates 
hepatocyte adherens junctions in response to increased actomyosin contractility by 
increasing myosin II light chain gene expression (Bai et al., 2016). Also there, the 
transcriptional, nuclear role of YAP was required for junctional regulation, although 
the described mechanism was different. However also in ECs YAP/TAZ regulate 
actomyosin contraction (Kim et al., 2017), so possibly both mechanisms act together 
in regulating junctional proteins. Together, these findings indicate the existence of a 
positive feedback loop where stable junctions sequester YAP and TAZ from the 
nucleus, therefore maintaining less junctional turnover, while remodelling junctions 
allow YAP and TAZ to relocate to the nucleus where they increase VE-Cadherin 
turnover. 
In addition to the regulation of adherens junctions, Kim and colleagues found 
decreased levels of the tight junction proteins ZO-1 and Claudin-5 in retinas from 
YAP/TAZ iEC-KO mice (Kim et al., 2017). Although in my model I did not observe 
brain haemorrhages at P6, other labs did report them, perhaps in connection to the 
use of a different Cre line to induce YAP/TAZ deletion in ECs (VE-Cadherin Cre)(Kim 
et al., 2017, Wang et al., 2017). 
 
8. YAP/TAZ,	migration	and	the	actin	cytoskeleton	
 
I analysed the directional cell migration using the scratch wound assay and 
inferred the non-directional rearrangements of cells by their position in the 
monolayer, and concluded that YAP/TAZ both increase the directional cell migration 
and the individual rearrangements of cells. Interestingly, my conclusions are 
supported by Wang and colleagues that analysed the migration tracts of live cells 
and similarly observed that the loss of YAP/TAZ decreases the random movement of 
ECs (Wang et al., 2017). Mechanistically, I showed that YAP/TAZ promotes actin 
branching and the formation of JAILs, which are necessary for cell migration. In a 
complementary way, other labs focusing on the actomyosin cytoskeleton reported on 
YAP/TAZ being required for the formation of filopodia (Kim et al., 2017), lamellipodia 
(Wang et al., 2017, Sakabe et al., 2017) and contractility (Kim et al., 2017). 
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Transcriptome analysis of isolated brain ECs from YAP/TAZ iEC-KO pups 
and chromatin immunoprecipitation sequencing analysis showed that YAP/TAZ 
directly up-regulate genes linked to cytoskeletal remodelling (MACF1, FLNB, 
MICAL3, CTGF) (Wang et al., 2017). My data shows that BMP signalling repression, 
which is caused by the transcription of BMP inhibitors, is partially responsible for the 
migration defect. Together, these results suggest that the nuclear, transcriptional role 
of YAP/TAZ, are required for cell migration. Curiously, Sakabe and colleagues found 
that cytoplasmic but not nuclear YAP increases Cdc42 activity in lamellipodia and 
phosphorylation of N-WASP (Sakabe et al., 2017), an actin binding protein that 
promotes branching of actin through the activation of the Arp2/3. They also showed 
partial rescue of the migration defect by expressing a constitutively active form of 
Cdc42. It is thus likely that YAP/TAZ promote endothelial cell migration by more than 
one molecular mechanism. 
 
9. YAP/TAZ	and	the	regulation	of	BMP	signalling		
 
It was previously known that YAP/TAZ could be regulated by BMP signalling 
(Yu and Guan, 2013). However, that YAP/TAZ can in turn regulate BMP signalling 
had not been appreciated before, and this in spite of the classical YAP/TAZ target 
gene CTGF being a known BMP antagonist (Abreu et al., 2002). Here, I clearly show 
that YAP/TAZ modulate BMP signalling in ECs and that some of the cellular 
functions of YAP/TAZ are dependent on BMP signalling repression. In particular, the 
increased permeability of YAP/TAZ knockdown cells is completely rescued by 
decreasing BMP signalling. This result is in accordance with previous data showing 
that BMP2 (Hussein et al., 2014) and BMP6 (Benn et al., 2016) increase EC 
permeability. In ECs, YAP/TAZ promote the transcription of the BMP signalling 
antagonists CTGF, NOG, FST and others. In particular, CTGF directly binds to BMP4 
decreasing its binding to BMP receptors (Abreu et al., 2002). In ECs, CTGF 
increases the migration of cells in vitro and promotes the extension of filopodia and 
the growth of the vascular plexus in the mouse retina (Pi et al., 2011), so at least part 
of the YAP/TAZ loss of function phenotype might be caused by the lack of CTGF 
expression. In vivo rescue experiments using CTGF and other BMP antagonists will 
be required to determine if one or several of them cause, and to what extent, the 
YAP/TAZ loss of function phenotype. 
In addition to the precise relevant BMP antagonist being undetermined, 
further research will need to clarify the specific ligands/ receptors involved, and what 
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their roles are in the context of YAP/TAZ loss. While my in vitro results suggest an 
increase in the BMP2/4 – ALK3 pathway, this pathway was previously shown to be 
pro-angiogenic (Lee et al., 2017), which goes against the antiangiogenic phenotype 
of YAP/TAZ loss.  
 
10. Unique	 and	 redundant	 roles	 of	 YAP	 and	 TAZ	 during	 blood	 vessel	
formation	
 
Unlike certain organs where the single deletion of YAP leads to dramatic 
developmental defects (for example, the skin (Schlegelmilch et al., 2011), kidneys 
(Reginensi et al., 2013) and lung (Lin et al., 2017)), ECs require both YAP and TAZ 
during blood vessel development.  
YAP and TAZ show some redundant and some unique roles. The nature of 
this partial redundancy is most likely explained by the high degree of structural 
similarity between the two proteins. In ECs, it seems that TAZ evolved to play a more 
important role as a nuclear transcriptional co-activator in sprouting ECs, while YAP 
seems to be more relevant in the cytoplasm of all ECs. My stainings in WT retinas 
support this idea, as do the luciferase assays and qPCR data that in general show a 
higher transcriptional effect for TAZ. Furthermore, my experiments with Yap EC-KO 
mice suggest that TAZ has a preferential nuclear location: when increasing the 
expression of TAZ by deleting YAP, nuclear expression of TAZ is seen not only at 
the sprouting front, where it is increased, but also in veins, where no nuclear YAP or 
TAZ are present in WT conditions. Moreover, only the single deletion of TAZ, but not 
of YAP, decreases the number of sprouts. This does not mean that YAP is not 
required for sprouting ECs – the results with the double mutants show the contrary, 
but the function of YAP in the endothelium might be different and not restricted to 
sprouting. Curiously, I found that in the single mutants only the deletion of YAP, but 
not of TAZ, led to decreased endothelial proliferation. However, experiments with 
gain of function forms of YAP and TAZ showed opposite results. While the 
expression of a constitutively active form of YAP in ECs did not increase endothelial 
proliferation (Sakabe et al., 2017), the constitutively active form of TAZ did (Neto et 
al., 2018). It is possible that YAP and TAZ increase EC proliferation by different 
mechanisms – that of YAP in transducing signals from mechanical stimulation and of 
TAZ by promoting pro-proliferatory genes. YAP is, unlike TAZ, much more expressed 
in the cytoplasm of ECs in vivo and is not only in sprouting vessels, but also in more 
mature, quiescent vessels. This suggests on the one hand that YAP plays a 
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cytoplasmic role, and on the other hand that it is required during vessel maintenance. 
Interestingly, Sakabe and colleagues showed that cytoplasmic YAP, but not nuclear 
YAP, is required for endothelial cell migration as it activates Cdc42 (Sakabe et al., 
2017). In vivo, they showed that while YAP/TAZ iEC-KO retinas display signs of 
proliferation and migration defects, the LATS1/2 iEC-KO, that causes nuclear YAP 
and TAZ accumulation, only showed proliferation but not migration defects (Sakabe 
et al., 2017). In the zebrafish vasculature, the deletion of YAP leads not to sprouting 
defects but to vessel collapse (Nakajima et al., 2017), suggesting a role for vessel 
maintenance in that system. 
 
11. Future	work	and	perspectives	
Here, I have uncovered an important role of YAP and TAZ during blood 
vessel development in the mouse retina. Future research will determine how much 
these functions are maintained in other vascular tissues and during maintenance, 
response to injury and pathological angiogenesis. Interestingly, YAP and TAZ are in 
other cells heavily regulated by the mechanical stiffness of the tissue they contact. If 
ECs can perceive the stiffness of the tissue through the basement membrane is not 
known, as also if YAP and TAZ are differently expressed in tissues in different 
stiffness. It will definitely be interesting to investigate if because of this YAP and TAZ 
are involved in tissue specific vasculature differences. In the same line of thought, it 
will be interesting to investigate if conditions that affect vascular stiffness, as 
atherosclerosis and vascular calcification, affect endothelial YAP/TAZ and if 
YAP/TAZ are involved in the pathogenesis process. On this regard, a previous study 
showed increased nuclear localization and activation of YAP/TAZ in atheroprone 
areas of the endothelium in mouse arteries, and a reduction in the size of 
atherosclerotic lesions after targeting YAP/TAZ by morpholinos (Wang et al., 2016), 
suggesting that YAP/TAZ may be a promising target in atherosclerosis. Finally, 
another remaining question is if YAP and TAZ impact tumour angiogenesis. Data 
showing nuclear YAP/TAZ in glioblastoma tumour vessels in comparison with their 
normal cytoplasmic location in cortical vessels suggests that YAP/TAZ may be 
involved in pathological angiogenesis (Wang et al., 2017). Importantly, clinically 
targeting YAP/TAZ requires the use of inhibitors or activators of the pathway. As 
upstream regulators and molecular mechanisms are uncovered, various drugs 
targeting different areas of the pathway are being tested (Zanconato et al., 2016). To 
those, I here add the possibility of targeting BMP antagonists as a way to modify 
YAP/TAZ functions. More research, especially in the in vivo situation, will evaluate 
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how much these drugs are applicable and can change disease progression and 
outcomes.
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